Next Article in Journal
Induction of Autophagy by Extract from Corydalis heterocarpa for Skin Anti-Aging
Next Article in Special Issue
Seaweeds as Source of Bioactive Pigments with Neuroprotective and/or Anti-Neurodegenerative Activities: Astaxanthin and Fucoxanthin
Previous Article in Journal
Effects of Polymannuronic Acid on the Intestinal Microbiota in Mice after Long-Term Intragastric Administration
Previous Article in Special Issue
Synthesis and Hypoglycemic Effect of Insulin from the Venom of Sea Anemone Exaiptasia diaphana
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Current Status of Indole-Derived Marine Natural Products: Synthetic Approaches and Therapeutic Applications

by
Sergio Fernández
1,
Virginia Arnáiz
2,
Daniel Rufo
2 and
Yolanda Arroyo
3,*
1
Department of Chemistry, School of Physical and Chemical Sciences, Queen Mary University of London (QMUL), Mile End Road, London E1 4NS, UK
2
Department of Organic Chemistry, Science Faculty, University of Valladolid (UVa), Paseo de Belén 7, 47011 Valladolid, Spain
3
Department of Organic Chemistry, ITAP, School of Engineering (EII), University of Valladolid (UVa), Dr Mergelina, 47002 Valladolid, Spain
*
Author to whom correspondence should be addressed.
Mar. Drugs 2024, 22(3), 126; https://doi.org/10.3390/md22030126
Submission received: 15 February 2024 / Revised: 29 February 2024 / Accepted: 2 March 2024 / Published: 6 March 2024

Abstract

:
Indole is a versatile pharmacophore widely distributed in bioactive natural products. This privileged scaffold has been found in a variety of molecules isolated from marine organisms such as algae and sponges. Among these, indole alkaloids represent one of the biggest, most promising family of compounds, having shown a wide range of pharmacological properties including anti-inflammatory, antiviral, and anticancer activities. The aim of this review is to show the current scenario of marine indole alkaloid derivatives, covering not only the most common chemical structures but also their promising therapeutic applications as well as the new general synthetic routes developed during the last years.

1. Introduction

Marine organisms constitute an important source of natural products with tremendous biological and chemical diversity. Sponges, algae, corals, marine bacteria, and fungi were shown to produce new secondary metabolites that may be the key to the production of new drugs to treat various diseases [1,2]. In this regard, marine natural products have important advantages over those of terrestrial origin, including chemical novelty, new mechanisms of action, and greater biological activity. These valuable pharmacological properties can be explained due to the fact that many marine compounds have evolved to fight for their organism survival, becoming very powerful inhibitors of biological processes in the predators of the marine organisms that utilize them for survival. [3]. The anticancer drugs Trabectedin (Yondelis®; Figure 1) and Eribulin mesylate (Halaven®; Figure 1) are examples of marine drugs accepted by the FDA that proceed by a novel mechanism of action [4,5]. On the other hand, the cyclic depsipeptide Largazole, isolated from a cyanobacterium, is one of the most potent class I histone deacetylase inhibitors, and the first cyanobacterial secondary metabolite containing a thioester (Figure 1) [6,7].
As stated before, marine organisms have proven to be an outstanding source of active molecules, with indole derivatives being one of the most promising [8]. Chemically, indole (2,3-benzopyrrole) consists of benzene and pyrrole rings fused together. Indole is an important industrial product widely used in the production of fragrances [9], medicines [10], exogenous auxins [11], and colorants like indigo. The indolyl group is an important fragment present in a wide variety of natural products, such as the amino acid Tryptophan (Trp), which is involved in the synthesis and release of the neurotransmitter serotonin (related to mood), the hormone melatonin (which regulates sleep), indole alkaloids, and the plant hormone auxin. Therefore, this moiety has also received much attention in the fields of synthetic organic chemistry and medicinal chemistry [8]. Importantly, recent research has shown clear evidence of the relationship between the chemical structure of the indole bicyclic skeleton and the biological activity it presents. In this sense, anticancer [12,13,14], anti-coronavirus [15,16], and anti-diabetic [17,18,19,20] activities are observed when there are amide or chalcone groups at the C2 and/or C3 positions of the indolyl group. Anti-Alzheimer’s disease activity [21] is observed when seven-membered nitrogen-containing heterocycles are present at the C2 and/or C3 positions. Anti-inflammatory [22,23] and antifungal activities [24,25] are observed when different functional groups are placed at the N1 position. Finally, inhibition against osteoporosis [26] is observed when a thiophene group is installed at the C7 position (Figure 2).
Recently, Martinez et al. described several marine natural products as Breast Cancer Resistance Protein (BCRP) inhibitors [27]. Among them, three examples stand out: Fumitremorgin C (FTC), a prenylated indole alkaloid derived from the amino acids L-tryptophan and L-proline; Tryprostatin A, a natural analog of FTC formed by the condensation of a proline unit and an isoprenyl tryptophan residue into a diketopiperazine unit; and the β-carboline alkaloid Harmine (Figure 3). It is noteworthy to mention that all these compounds are indole alkaloids.
Undoubtedly, many compounds derived from marine sources have marked milestones in the treatment of diseases. In particular, indole-containing alkaloids, one of the largest, most abundant, and most chemically diverse family of natural compounds, have been shown to have outstanding potential in the development of new drug leads. However, there are still many obstacles to overcome, in particular the devastating side effects and the fact that many cancers develop resistance to several important pharmaceuticals. For these reasons, it is necessary to continue searching for new, safer, and more efficient drugs. Within this context, the structural and functional versatility of indole alkaloid derivatives spots them as privileged scaffolds that could streamline the discovery of chemical analogs with potential applications in drug discovery. Therefore, the purpose of this review is to exclusively cover indole alkaloid derivatives from marine sources with a therapeutic interest, as well as the novel synthetic routes described to obtain these versatile compounds. The relationship between their chemical structure and bioactivity is also addressed in those cases that are described in the literature.

2. Marine Indole Alkaloids

Marine Indole Alkaloids (MIAs) present many different structural features and exhibit wide biological activities such as anti-inflammatory, anticancer, anti-HIV, antibacterial, antifungal, and anti-diabetes activity, among many others. Both aspects require being organized and ordered. In this section, the origin and therapeutic applications of MIAs are presented. Furthermore, synthetic routes from a large number of MIA families have also been included. Based on chemical structures, indole alkaloids can be classified into three groups: simple indole alkaloids, prenylated indoles, and annelated indoles.

2.1. Simple Indole Alkaloids, (SIAs)

Simple indole alkaloids consist of an indole nucleus with distinct substitution patterns at the N1, C3, C4, C5, C6, C7, and C8 positions [28,29]. In this section, the compounds of this group are ordered according to the complexity of the substituents of the indole moiety, starting from acyclic to cyclic ones.

2.1.1. C3-Acyclic Substituted Simple Indole Alkaloids

The most common substitution in simple indole alkaloids occurs at the C3 position, a characteristic observed in many families of simple alkaloids [8,30]. Various examples showcase the biological activities of these compounds (Figure 4). For instance, tryptophol (2-(1H-Indol-3-yl)ethan-1-ol, 1) isolated from the marine sponge Ircinia spiculosa, showed sleep-inducing activity [31]. On the other hand, 2-(1H-indol-3-yl)ethyl 2-hydroxypropanoate (2), isolated from the yeast strain (USF-HO25) of a marine sponge identified as Pichia membranifaciens, exhibits a mild response as a radical scavenger of 2,2-diphenyl-1-picrylhydrazyl (DPPH) [32]. Another example is methyl 1H-indole-3-carboxylate (3), obtained from Spongosorites sp., a marine sponge, demonstrating cytotoxic attributes against several human cancer cell lines [33]. Additionally, Hainanerectamine B (4), isolated from Hyrtios erecta, a marine sponge from Hainan, has shown the ability to inhibit Aurora A, a serine/threonine kinase involved in the regulation of cell division [34]. Finally, Tryptamine (5), was obtained from Fascaplysinopsis reticulata, a lyophilized sponge, and demonstrated antibacterial and growth inhibition activity towards Vibriocarchariae (MIC = 1 μM) [35].
The presence of carbonyl or carboxyl groups in the indole ring has demonstrated different and interesting biological activities [28,36,37]. Compound 6, an indole carbaldehyde obtained from E. chevaleri KUFA 0006, a culture of an endophytic fungus, exhibited inhibitory activity against S. aureus ATCC 2592 biofilm settlement [38]. Hytiodoline (7) an indole amino acid obtained from the Hyrtios sponge, demonstrated potent anti-trypanosomal activity [39]. Becillamide A (8), a thiazole indole derivative obtained from Bacillus sp. marine bacterium, showed antibiotic activity against Archangium gephyra, immunosuppressing the myxobacterium [40]. Anthranoside (9), containing a carboxylated aniline, was obtained from the sponge-originated actinomycete, Streptomyces sp. CMN-62, and exhibited anti-influenza activity against the H1N1 virus and inhibited the reaction to NFκB [41]. Hermanine D (10), isolated from ascidian Herdmania momus, could inhibit the mRNA expression of iNOS, consequently provoking an anti-inflammatory effect [37] (Figure 5).
Quia Che and coworkers developed a biogenetic route to obtain Anthranoside C (11), starting with anthranilic acid (12) and D-glucose (13). The process involves linking two 12 molecules to a 13 molecule, to create a benzenaminium salt; the subsequent cyclization creates the indole ring and, in one further step, the Anthranoside C (11) [41] (Figure 6).
The prenylated simple indoles have also demonstrated diverse and fascinating biological activities [28,36,37]. In this sense, the prenylated indole carbaldehyde (14), obtained from E. chevaleri KUFA 0006, exhibited inhibitory activity against S. aureus ATCC 2592 biofilm settlement [37]. Eurotiumin (15), an amide indole derived from Eurotium sp. SCSIO F452, a sediment-derived fungus from the South China Sea [42], showed antioxidant properties in a DPPH assay [43]. Misszrtine A (16), an unusual N-substituted prenylated indole obtained from Aspergillus sp. SCSIO XWS03F03, a sponge-derived fungus, exhibited strong activity against HL60 and LNCaP cell lines [44]. Terpetin (17), a polyamide indole obtained from Aspergillus sp. SpD081030G1f1, acted as a protector against L-glutamate toxicity in cells [45] (Figure 7).
May Zin et al. proposed the biogenesis of isomer compounds 18 and 19, starting with L-tryptophan (20). Isomer 17 was obtained in five steps, and isomer 19 required one additional isomerization step (Figure 8) [38].
The compounds described above have underscored the potential of indole alkaloids in both organic and medicinal chemistry, emphasizing the importance of exploring synthetic pathways to obtain simple indole alkaloids. Some straightforward methods for obtaining functionalized simple indole alkaloids include the Bartoli reaction, which involves nitrobenzene (21) and vinylmagnesium bromides (22) [46]. Another reaction involves the intramolecular Rh-catalyzed decomposition of ortho-azydostyrenes (23), followed by C–H activation [47]. Additionally, two novel and high-yielding Au(I)-catalyzed reactions have been reported: one involving the intramolecular cyclization reaction of ortho-alkynylanilines (24) [48] and the other involving the reaction between alkynyl-hydroxycyclohexadienones (25) and primary amines [49] (Figure 9).

2.1.2. C3 (Iminoimidazolidin and Pyrazin)-Substituted Simple Indole Alkaloids

Usually, simple indole alkaloids are categorized into families based on similar structures, activities, or origins [36]. Some examples of this classification include Trachycladindoles and Aplysinopsin, both of which feature an iminoimidazolidine ring in the above position (Figure 10). Trachycladindoles A (26), C (27), G (28), B (29), D (30), E (31), and F (32), isolated from the marine sponge Trachycladus laevispirulifer, have demonstrated cytotoxicity against human cancer cells (HT-29, A549, and MDA-MB-231) [50]. Additionally, Aplysinopsin (33) and its derivatives 3440 were obtained from Thorectidae sponges (Thorectandra and Smenospongia) [51]. They demonstrated activity against Staphylococcus epidermidis, with derivative 38 exhibiting the highest antimicrobial activity (MIC = 33 μM). Following this, derivatives 36 (MIC = 36.5 μM), 35 (MIC = 74.6 μM), 34 (MIC = 98.3 μM), and 37 (MIC = 273.8 μM) showed decreasing levels of antimicrobial activity [36]. Derivative 34 was discovered in the Jamaican sponge Smenospongia aurea, and it exhibited a high affinity for two receptors, 5-HT2A and 5-HT2C [52]. The latest derivatives, 3940, were discovered in the marine sponge Fascaplysinopsis reticulata. They exhibited remarkable activity against the bacterium Vibrio natrigens.; derivative 39 demonstrated potent activity with a MIC of 0.03 μM, while derivative 40 exhibited significant activity (MIC = 2.4 μM) [35].
A hypothetical method for the biosynthesis of trachycladindoles has been described by A. Hentz. The route starts with tryptophan (20), and trachycladindole A–G (2632) is obtained in 5 steps [53] (Figure 11).
The synthesis of the Aplysinopsin derivate 39 is shown in Figure 12 and was described by Stanovnik and Svete [54]. The key step for the formation of the iminoimidazolinone core was achieved by the addition of methylamine to a carbodiimide intermediate, followed by an intramolecular amidation reaction.
Meridianins A–G (4147) are a family of SIAs characterized by having pyrazine rings at the C3 position (Figure 13). Meridianins are obtained from several sources, but mainly tunicates. Thus, the first was Aplidium meridianum, from which Meridianins A–E were isolated, [55] but other examples include Aplidium falklandicum and Synoicum sp. [56].
Meridianins B–E (4245) are notable for their demonstrated cytotoxic effects against adenocarcinoma and murine mammary tumor cell lines (IC50 = 11.4, 9.3, 33.9, and 11.1 μM, respectively) [55]. Moreover, 44 exhibited antibiofilm potential against methicillin-resistant Staphylococcus aureus (MRSA) [36]. In general, the Meridianin family demonstrated wide biological activities which are summarized in Table 1 [56,57].
Meridianins can be formed through several synthetic routes, the first one developed by Jiang and Yang from a 7-bromoindolylboronic acid (48) and a 4-chloro-pyrimidinyl-2-amine (49). In only two steps, 44 was obtained with a high yield [58] (Figure 14).
However, Fresneda and Molina’s methodology to obtain Meridianins 43 and 44 is the most used route to date. Starting from the corresponding brominated indoles, this four-step route presents high yields in all reactions [59] (Figure 15).
It is noteworthy to mention that most methodologies focus on the synthesis of 43 and 44 [58]. For example, Karpov et al. improved a three-component palladium-catalyzed carbonylated alkylation [60], while Müller and coworkers achieved it in a one-pot procedure based on Suzuki coupling following a Masuda borylation with a palladium catalyst [61]. Zhou and Chen developed a route to 43 and its derivatives [57], and Penoni employed the indolization of nitrosoarenes to obtain 43 derivatives with the indole moiety functionalized [62]. Remarkably, Stanovnik and Svete described the synthesis of Meridianins 4147 and the Aplysinopsins derivatives 3340 [54].

2.1.3. Bis-/Tri-Indole Alkaloids

Bis- and tris-indole alkaloids are characterized by the linkage of the indole moieties through (hetero)carbonated chains, typically between the C3 positions [36]. Usually, when indole alkaloids are bridged by an imidazole ring, they exhibit interesting biological activity. Examples of such cases are bis-indoles Dihydrospongotine C (50), Spongotine C (52), and the tris-indole Tulongicin (54), isolated from the sponge Topsentia. They have demonstrated antiviral activity against HIV, HxB2, and YU2, with IC50 values ranging from 2.7 to 12 μM and 3.5 to 9.5 μM, respectively, as well as antimicrobial and antibacterial properties, particularly against S. aureus (MIC = 1.8 to 7.6 μM) [63] (Figure 7). Furthermore, Rhopaladin C (53), isolated from a marine tunicate, demonstrated antimicrobial efficacy against Sarcina lutea and Corynebacterium xerosis (IC50 = 36.9 μM) [64]. Lastly, Spongotine A (51) was isolated from the Topsentia pachastrelloides sponge and showed antibacterial effects against both the susceptible and methicillin-resistant strains of S. aureus [65] (Figure 16).
Bromodeoxytopsentin (55) and dibromodeoxytopsentin (56) feature an unsaturated imidazole bridging the indole moiety (Figure 17). Compound 55, isolated from the Topsentia pachastrelloides sponge, demonstrated antibacterial effects against both the susceptible and methicillin-resistant strains of S. aureus [65]. Compound 56, obtained from a genus of the marine sponge Topsentia, also exhibited antibacterial properties against S. aureus (MIC = 22.7 μM) and showed additional potential as an antiviral agent against HIV (YU2, IC50 = 57 μM) [63].
Eusynstelamides A–B (5758) and D–F (5961) are brominated bis-indoles bridged by a γ-lactam ring obtained from ascidians [66] and bryozoans [67] (Figure 18). Compounds 57 and 58 displayed only weak effectiveness against S. aureus [66]. However, compounds 5961 proved stronger antibacterial properties, showing activity against S. aureus and Corynebacterium glutamicum (MIC = 7.8–17.4 μM), as well as E. coli and P. aeruginosa (MIC = 16.4–34.7 μM) [67].
Hamacanthins A–B (6263) are bis-indole isomers linked by a pyrazinone ring, isolated from a marine sponge belonging to the genus Hamacantha (Figure 19). Both exhibited antimicrobial properties and efficacy against B. subtilis (MIC = 6.4 and 3.3 μM respectively) [68].
Regarding the synthesis of bis- and tris-indole species, an illustrative example could be the synthesis of Rhopaladin C (53), developed by Janosik et al. [64]. Starting from 1H-indole-3-carbonyl cyanide, the desired product could be obtained by condensation of the nitrile group with the amino group from the L-Tryptophan methyl ester to generate the imidazolone core. This transformation yields 53 in two steps with a moderate yield (Figure 20).

2.2. Prenylated Indole Alcaloids (PIAs)

Prenylated indoles include several different families of compounds. For better insight for the readers, the PIAs are arranged in ascending order of complexity, ranging from an indole core with a cyclic prenyl substituent to an indole moiety fused with a variable number of prenyl-derived ring systems. PIAs containing the indole core with acyclic prenyl substituents are included in Section 2.1.

2.2.1. Diketopiperazine (DKP) Indole Alkaloids

Simple Diketopiperazines

Simple 2,5-diketopiperazines (2,5-DKPs) are cyclodipeptides formed through the condensation of two α-amino acids, establishing two amide linkages to form the six-membered ring [69,70]. This kind of compound demonstrated a good catalytic performance in the asymmetric synthesis of the Reformatsky reaction [71]. Furthermore, they have been used as structural fragments in the design of novel drugs [53].
Based on their chemical structure, simple indole diketopiperazines include a wide variety of families of compounds [71]. Then, DKPs, that have been found to have biological activities, have been ordered by increasing structural complexity into two main groups: monoindole and bisindole DKPs. Further, monoindole DKPs differ in how the indole is attached to the diketopiperazine, being ultimately divided by the attachment at C3 with a methylene or ethylidene bridge (Figure 21).

Attached at C3 with a Methylene Bridge

This classification has been organized according to the monoindole diketopiperazines containing a diketopiperazine ring attached at the C3 indol core with a methylene bridge (Figure 22 and Figure 23). These indole DKPs are commonly isolated from fungi, such as Aspergillus, and Penicillium, among others [72]. An example of a marine bioactive indole diketopiperazine alkaloid is Brevianamides, which originated from tryptophan and proline.
The simplest member of this family of compounds is the (S)-Brevianamide F (64), derived from the hexahydropyrrolopyrazine and is a precursor of a variety of more complex prenylated alkaloids. Compound 64, isolated from the marine-derived Penicillium vinaceum, showed antibacterial activities against Bacille Calmette-Guérin (BCGs) (IC50 = 44.1 µM) and S. aureus, with antifungal activity against C. albicans [73,74]. (R)-Cyclo(D-Trp–L-Pro) (65), the enantiomer of Brevianamide F (64) isolated from the fungi, showed antimicrobial activities [75]. Compound 66, derived from the fungus Aspergillus fumigatus, bears an N-tert-butoxycarbonyl protecting group which increases its antimicrobial activity against S. aureus and B. subtilis (IC50 = 2.1–3.3 μg/mL) [76].
Another two examples, whose structures derived from the hexahydropyrrolopyrazine, are 18-Oxotryprostatin A (67) and compound 68, both isolated from the marine-derived fungus Aspergillus sydowi. 18-Oxotryprostatin A (67) exhibited weak cytotoxic activity against A-549 cells (IC50 =1.28 µM) [77]. Compound 68 showcased antimicrobial activity against S. aureus and B. subtilis (IC50 = 2.1–3.3 μg/mL). This activity was strongly enhanced due to the C2-isoprene and N-tert-butoxycarbonyl units [76].
8,9-Dihydrobarettin (69), a brominated cyclodipeptide found in the boreal sponge Geodia barretti, exerted inhibitory activity against AChE and BChE, and potent antifouling, antioxidant, and anti-inflammatory activities, making it a potential lead compound in the prevention of chronic inflammatory diseases [78,79]. Further, it displayed a high affinity for the 5-HT receptor [79,80].
Cyclo(L-Trp–L-Ala) (70), Rubrumlines F (71), G (72), J (73), M (74), N (75), and O (76), 5-Piperazinedione 77, 2,5-piperazinedione 78, and Preechinulin (79), found in the marine-derived fungus Eurotium rubrum, demonstrate an effect against the influenza virus strain A/WSN/33 (H1N1) [81]. Echinulin (80), extracted from the marine-derived fungus Eurotium rubrum MPUC136, presents two isoprene units in the indole core and showed inhibitory activity against B16 melanoma cells [81,82].
The diketopiperazine 78, obtained from the M-3 strain belonging to the Ascomycota phylum, exhibited strong and selective antifungal activity against Pyricularia oryzae.
14-Hydroxyterezine D (81) was derived from Aspergillus sydowi PFW1-13 and showed weak cytotoxic activity towards A549 (IC50 = 7.31 µM). Further, it was active against HL-60 cells (IC50 = 9.71 µM) [77]. Didehydroechinulin (82) was isolated from Eurotium cristatum EN-220 and showed potent lethal activity against brine shrimp and a weak nematicidal effect against Panagrellus redivivus (IC50 = 27.1 μg/mL) [83]. Both have one and two isoprene units in the indole core respectively.

Attached at C3 with an Ethylidene Bridge

Isoechinulin B (83), Cryptoechinuline G (84), and alkaloid E-7 (85) have been isolated from the marine-derived fungus Eurotium rubrum MPUC136 [84], and feature several isoprene units in the indole core. They exhibited inhibitory activity against melanin synthesis using B16 melanoma cells [81,82]. Demethyl-12-oxo-eurotechinulin B (86), obtained from the same fungal strain, showed cytotoxic activity against the SMMC-7721 cell line (IC50 = 30 μg/mL) [43] (Figure 24).
Cristatumin A (87), isolated from Eurotium cristatum EN-220, showed antibacterial activity against S. aureus and E. coli (IC50 = 64 and 8 μg/mL). As far as we can ascertain, its synthesis has not been reported yet [85]. Aspechinulins C (88), isolated from the fungus Aspergillus sp. FS445, exhibited the most potent inhibitory activities against nitric oxide (NO) production in comparison to other Aspechinulins compounds (IC50 = 20–90 mM) [86].
Barettin (89) is a brominated cyclodipeptide isolated from the boreal sponge Geodia barrette. Like its reduced analog 8,9-dihydrobarettin (69), it exhibited inhibitory activities, such as potent antifouling, antioxidant, and anti-inflammatory activities, and reduced the DC secretion of IL-12p40 and IL-10 (IC50 = 21.0 and 11.8 μM, respectively) [78,79,80].
Neoechinulin A (90), isolated from the marine-derived fungus Aspergillus sp., and Variecolorin O (91), extracted and characterized from the Eurotium sp. SCSIO F452 fungus, exhibited significant radical scavenging activity against DPPH [42]; compound 90 also showed UV-A protecting activity (IC50 = 24 μM) [87]. Isoechinulin A (92), isolated from the Eurotium rubrum MPUC136 fungus, showed inhibitory activity against the influenza A/WSN/33 virus (IC50 = 42.7 μM) [81,82].
Compound 93 was isolated from Eurotium cristatum EN-220 and showed potent lethal activity against brine shrimp and a weak nematicidal effect against Panagrellus redivivus (LD50 = 110.3 μg/mL) [83].
Neoechinulin B (94), Neoechinulin C (95), Rubrumline D (96), and Rubrumline E (97), obtained from the Eurotium rubrum fungus, had weak antiviral effects against the influenza virus strain A/WSN/33 (H1N1) that was propagated in MDCK cells [81].
Eurotiumin C (98), isolated and characterized from the Eurotium sp. SCSIO F452 fungus, showed significant radical scavenging activities against DPPH (IC50 = 13 μM) [42].
Photopiperazines A–D (99102), unsaturated diketopiperazine derivatives, were isolated from the Actinomycete bacterium strain AJS-327 and exhibited selective toxicity toward U87 and SKOV3 lines (IC50 = 4.1 × 10−4 μM and 7.5 × 10−4 μM) [88] (Figure 24).

Bis-Indole Diketopiperazine

In this subsection, naturally occurring DKPs with biological activity that contain two indole units are been summarized (Figure 25) [89]. Aspergilazine A (103), isolated from the marine-derived fungus Aspergillus taichungensis ZHN-7-07, contains a rare N1 to C6 linkage between two DKPs. Compound 103 has weak activity against the influenza A (H1N1) virus with an inhibition of 34.1% at a concentration of 50 μg/mL [90,91].
Brevianamide S (104), extracted from the marine-derived fungus Aspergillus versicolor, showed antibacterial activity against BCGs (IC50 = 9.0 µM) [73,74].
Dinotoamide J (105), obtained from a marine-derived fungus called Aspergillus austroafricanus Y32-2, demonstrated angiogenesis-promoting activity and exhibited proangiogenic activity in a PTK787-induced vascular injury zebrafish model [92].

Synthetic Routes of DKPs

To obtain indole DKP derivatives, there are two key steps in every synthetic route: the synthesis of the DKP core, and the coupling of the DKP and the indole unit. Regarding the construction of the DKP ring, three immediate disconnections of a 2,5-diketopiperazine ring can be envisioned: the amide bond at N1–C2 (A), the N1–C6 bond (B), and the C5−C6 bond (C). Additionally, two other possible disconnections involving two bonds can be devised: tandem cyclization via N1−C2/C3−N4 (D) and via C2−N1− C6 (E) (Figure 26).
The amide bond formation (A) can be carried out through four different methods: dipeptide formation followed by cyclization, Ugi chemistry, amino acid condensation, and Aza-Wittig cyclization. The N-alkylation synthesis (B) can be approached in three different ways: using α-haloacyl derivatives of amino acids, the aza-Michael reaction, and the Diels−Alder reaction. The approach C can occur via C–C cyclization radical-mediated or enolate acylation [71]. The tandem cyclization synthesis (D and E) can be regarded as extensions of (A–C), and they share some common processes in tandem fashion.
Given the straightforward character of the procedure and the huge chiral pool of commercially available α-amino acids, there are several synthetic examples of the dipeptide route using different coupling reagents.
A representative case of an intramolecular aza-Wittig reaction forming the 2,5-DKP ring is provided in Figure 27. The acylation between amino acids esters (106) and chloroacetyl chloride, followed by treatment with sodium azide (NaN3) and Ph3P, creates 2,5-diketopiperazine 107 via iminophosphorane intermediates [93].
Considering the obtention of indole DKPs, many methods of synthesis and biosynthesis have been described over decades, but surprisingly very few of them were employed to create biologically active compounds. As illustrative examples, the reported synthesis and biosynthesis of Brevianamide F (64) are depicted in Figure 28. Nicolás et al. carried out a solid phase methodology following the Ashnagar synthesis, which furnished 63 in very good yields but required the installation–removal of protecting groups (Figure 28a) [94,95]. On the contrary, the biosynthesis approach of 64 uses directly unprotected L-Trp (20) and L-Pro (108) as precursors. This way, using FtmPS (a nonribosomal peptide synthetase) from Aspergillus fumigatus as a catalyst, Brevianamide F (64) can be obtained (Figure 28b) [69].
The synthesis of Neochenulin A (94) is an example of a diketopiperazine attached at C3 with an ethylidene bridge. The reaction of the aldehyde 109 and diketopiperazine 110 promoted t-BuOK in DMF and created the C3-ethylidene-bridged indole DKP core in one step. The subsequent deacetylation and elimination of the methoxymethyl group (MOM) created target compound 94 (Figure 29) [96].
An example of the synthesis of a dimer of the natural product brevianamide F (64), aspergilazine A, involves a selective palladium-catalyzed indole N-arylation with brevianamide F (64) and N-Boc bromo derivative 111. It had an excellent yield of the product 112, which, upon facile deprotection, formed Aspergilazine A (103) (Figure 30) [75].

DKPs Featuring Dimethylpyranoindole

Firstly, DKPs containing a hydropyran[3,2-f]indole nucleus were described. In this sense, Asperversamides (113116) (Figure 31) were extracted from the filamentous fungus Aspergillus versicolor, collected from the mud in the South China Sea [97]. All of them contain a rare, linearly-fused dimethylpyranoindole. All these DKP alkaloids exhibited potential iNOS inhibitory activities, related to anti-inflammatory activity. The best IC50 value was for compound 114 (5.39 μM), whose planarity was found to be important for its binding capacity to form strong hydrogen bonds with the HEME [97]. Studies of structural elucidation showed that compound 113 is a C17 epimer of Dihydrocarneamide A (117). This carneamide derivative, and Iso-notoamide B (118), came from the marine-derived endophytic fungus Paecilomyces variotii EN-291 and exhibited weak cytotoxic activity against NCI-H460 (IC50 = 69.3 and 55.9 μM, respectively) [98].
Notoamides are a large family containing a hydropyran[3,2-e]indole, isolated from the Aspergillus species of fungi. Biosynthetically, they are related to breviamides, paraherquamides, marcfortines, sclerotiamides, asperalines, avrainvillamides, and stephacidins [99,100]. The presence of a bicyclo[2.2.2]diazaoctane (Figure 32) in their structures causes many of these alkaloids to display a variety of biological activities [101]. Thus, Notoamides (119122) showed moderate cytotoxicity against HeLa and L1210 cell lines (IC50 = 22–52 μM). Furthermore, Notoamide C (121) and 5-Chlorosclerotiamide (123) had potent anti-fouling and antilarval settlement activities against Bugula neritina [102]. Likewise, 17-O-ethylnotoamide M (124) did not display cytotoxicity against non-malignant HEK 293 T9 and MRC-9 cell lines and inhibited the colony formation of 22Rv1 cells, related to resistance against hormone therapy for prostate cancer [103].
6-epi-Avrainvillamide (125) and 6-epi-Stephacidin A (126) were isolated from Aspergillus taichungensis and exhibited significant activities against HL-60 (IC50 = 4.45 and 1.88) and A549 (3.02 and 1.92) cell lines [104]. Asperthins A,F (127,128), extracted from a culture of Aspergillus sp. YJ191021, displayed moderate anti-inflammatory activity by measuring the secretion of the inflammatory factor 1L-1β by THP-1 cells [105]. Versicamide H (129), containing an eight-membered hexahydroazocine ring, was obtained from A. versicolor HDN08-60 and showed moderate activity against HeLa, HCT-116, HL-60, and K-562 cell lines and PTK inhibitory activities [106].

Synthesis of Brevianamides Bicyclo[2.2.2]diazaoctano Alkaloids

The synthetic approach to brevianamides, from 1998 to 2017, has been reviewed by Lawrence et al. [107]. Recently these authors have developed a unified biomimetic synthetic strategy for preparing many of the known bicyclo[2.2.2]diazaoctane brevianamides (Figure 33).
The synthesis starts with the preparation of (+)-Dehydro-deoxybreviamide E (130) from L-tryptophan (20), in a five-step gram-scale procedure. Subsequent treatment with mCPBA, followed by exposure of the obtained dehydrobrevianamides E (131) to LiOH/H2O in water at room temperature, created the natural (+) enantiomers of Breviamide A (132) and B (133). The treatment of 130 with NCS, and then LiOH/H2O, produced Brevianamide X (134) and Z (135).

Synthesis General of Hydropyranoindole Alkaloids

The synthesis of natural products bearing a pyranoindole nucleus has been reviewed by Catalano et al. [108]. As seen, some marine indole alkaloids have a hydropyrano ring fused to the pyrrole in a linear or angular manner. In Figure 34, the last step of both synthetic procedures is shown [109,110].

Spirocyclic DKP Alkaloids

These prenylated indoles contain a spirocycle in their structures, linked at the indole or at diketopiperazine rings (Figure 35).
Eurotinoids A–C (136138) were characterized from the sediment-derived fungus Eurotium dp. SCSIO F452. All the spirocyclic alkaloids showed significant radical scavenging activities against DPPH (IC50 = 3.7–24.9 μM) [111].
Spirotryprostatin E (139) was isolated from the holothurian-derived fungus Aspergillus fumigatus and showed cytotoxicity against MOLT-4, A549, HL-60, and BEL-7420 [112].
Dihydrocriptoechinulin D (140) was isolated from a mangrove-derived fungus, Aspergillus effuses H1-1, and showed activity against P388 and HL-60 cell lines and inhibitory activity against topoisomerase I [113].
Variecolorins A–C (141143) were characterized by the sediment-derived fungus Eurotium sp. SCSIO F452. (+)-141 exhibited stronger antioxidative activity than (−)-141 against DPPH (IC50 = 58.4 μM and 159.2 μM respectively), while (+)-142 and (+)-143 showed more potent cytotoxicity against SF-268 (IC50 = 12.5 and 30.1 μM) and HepG2 cell lines (IC50 = 15.0 and 37.3 μM). (−)-142 and (−)-143 were inactive (IC50 > 100 μM), which indicated that different enantiomers might result in different biological activities [114].
Variecolortides A–C (144146) were obtained from a halotolerant fungus, Aspergillus variocolor B17, and displayed weak cytotoxicity towards the K562 human leukemia cell line [19]. They also showed an interesting caspase-3 inhibitory activity (associated with cellular apoptosis) [115].

Other Polycyclic DKP Alkaloids

These prenylated indoles contain a variable number of cycles in their structures. They are presented below in increasing order of complexity (Figure 36).
Two Fumitremorgin B (147,148) derivatives were isolated from the holothurian-derived fungus Aspergillus fumigatus and showed similar bioactivity to Spirotryprostatin E, previously described [112]. A structural analog, 13-O-Prenylverruculogen (149), containing a dioxolane cycle, exhibited potent insecticidal activity against brine shrimp (artemia salina) [116]. On the other hand, Prenylcycloprostratin (150) and 9-Hydroxifumitremorgin C (151), obtained from A. fumigatus YK-7, displayed activities towards U937 cell lines [117].
Drimentine G (152), isolated from marine-sediment actinomycete Streptomyces p. CHQ-64, showed cytotoxic activities against HCT-8, Bel-7402, A549, and A2780 cell lines [118].
Brevicompanins (153158) were isolated from the fungus Penicillium brevicompactum and exhibited anti-inflammatory activity associated with BV2 microglial cell lines [119]. Compound 153 also showed antiplasmodial activity. A structural analog, Shornephine A (159), with a diketomorpholine ring, was isolated from the marine sediment-derived Aspergillus sp. (CMB-M081F) and was identified as a non-cytotoxic inhibitor of the P-glycoprotein associated with MDR cancer cells [120].
Okaramine S (160) was produced by Aspergillus taichungensis ZHN-7-07, isolated from the rhizosphere soil of the mangrove plant Acrostichum aureum. It exhibited cytotoxic activity against HL-60 and K562 cell lines with IC50 values of 0.78 and 22.4 μM, respectively [121].
Deoxyisoaustamide derivatives (161,162), containing an eight-membered hexahydroazocine ring, were extracted from the fungus Penicillium dimorphosphorum KMM 4689 from soft coral samples. These compounds showed neuroprotective activity against the acute toxicity of paraquat (PQ) murine neuroblastoma Neuro-2a cells [103], with no cytotoxicity towards these neuro-cells.
Raistrickindole A (163), containing an oxindole ring, was extracted from Penicillium raistrickii IMB17-034 and showed activity against the hepatitis C virus (HCV) with an EC50 value of 5.7 μM [122].
Indotertine B (164) was isolated from the marine sediment-derived actinomycete Streptomyces sp. CHQ-64 [123] and exhibited cytotoxic activities against HCT-8, Bel-7402, A549, and A2780 cell lines with IC50 values of 2.81, 1.38, 1.01, and 2.54 μM, respectively [124].
Nocardioazine A (165), isolated from a marine sediment-derived bacterium, Nocardiopsis sp. (CMB-M0232) is an effective and noncytotoxic inhibitor of the multidrug resistance factor P-glycoprotein and is able to reverse resistance in SW620 Ad300 cells [125].

General Synthesis of Indole DKP Alkaloids

A general strategy for the synthesis of indole DKP alkaloids (Figure 37) has been described by Jia et al. [126]. Three types of analogs of indole DKP alkaloids were synthesized: fused pentacyclic indole DKPs (166), trypostatin open-ring indole DKPs (167), and spiropentacyclic indol DKPs (168 and 169).
The Pictet–Spengler reaction of methyl L-tryptophan hydrochloride 170 with several aldehydes leads to the corresponding chiral cyclic intermediate 171. The subsequent reaction of 171 with F-moc-L-Pro-Cl created 172, which, by treatment with morpholine, produced the fused pentacyclic indole DKP (166). When compound 172 is treated with NBS, it undergoes a spiro rearrangement providing the corresponding spiro-pentacyclic indoles, which, upon treatment with morpholine, generates the DKP derivative, 168 (R = alkyl). When the substituents are aromatic, open-ring indoles (167) are formed. Another approach for the preparation of the spiro-pentacyclic scaffold (169, R = aryl) used a 1,3 dipolar cycloaddition of 2-oxoindolin-3-ylidenes with azomethine ylides, followed by the previously described procedure (treatment with F-moc-L-Pro-Cl and morpholine).

2.2.2. Hexahydropyrrolo[2,3-b]indol (HPI) Derivatives

In this kind of alkaloid, the indole group from tryptophan is fused with an additional pyrrole ring (Figure 38), highlighted by a group of Flustramines isolated from the marine bryozoan Flustra foliacea [127]. The simple Flustramine C (173) showed activity to inhibit biofilm formation in A. baumannii, a human pathogen associated with hospital-acquired infections. A structural modification by adding a triazole amide moiety with a large hydrophobic chain at pyrrroloindole (174) increased the antibiofilm activity, from IC50 values of 174 μM to 3.4 μM, respectively [117].

Synthesis of Hexahydropyrrolo[2,3-b]indol (HPI) Derivatives

Several procedures have been described for the synthesis of a pyrroloindole scaffold. Below, the focus is on the synthetic routes for the preparation of Flustramines (Figure 39 and Figure 40) and on the known routes to build the HPI tricycle skeleton (Figure 41).

Synthesis of Flustramines

The general approach to Flustramines consists of tandem olefination, isomerization, and Claisen rearrangement to provide the intermediate 175. The successive deacetylation, and selective reduction of the nitrile group of compound 176 with subsequent cyclization, leads to pyrroloindole 177. A final methylation step creates Flustramine C (178) [35].
Bunders et al. [117] described an effective method to obtain Flustramine analogs 179 with a general scaffold. As indicated in Figure 40, a Fischer indolization reaction of hemiaminal 180 created the tricyclic core 181. The corresponding functionalization of 181 and final deprotection created the aforementioned product 179.

Synthesis of HPI Tricyclic Skeleton

The synthesis of HPIs has been quite extensively reviewed by Albericio et al. [128]. Figure 41 shows the most significant synthetic routes to obtain a wide variety of HPI alkaloid derivatives, using functionalized indoles, oxidized indoles, and tryptamines as starting materials. The usually described procedures involve classic approaches by cyclization, including acid-catalyzed, oxidative, reductive, and alkylative, with nucleophiles. Other procedures take place by [3,3]-sigmatropic rearrangement and Fischer indolization. On the other hand, complex structures were obtained by modern procedures, including Pd-catalyzed reactions such as Larock heteroannulations or aza-Pauson–Khand cyclocarbonylation.

2.2.3. Indolactam Alkaloids

Teleocidin analogs 182 and 183 were isolated from different Streptomyces sp., obtained from marine sponges. The first compound, 182, had neurological activity via the protein kinase C (PKC) pathway [37], while the second compound, 183, exhibited cytotoxicity against HeLa and ACC-MESO-1 cell lines (Figure 42).
Pendolmycin analogs 184 and 185 were isolated from actinomycete Marinactinospora thermotolerans SCSIO 00652. They showed antiplasmodial activities against the Plasmodium falciparum strains 3D7 and Dd2 [129].

2.2.4. Other Polycyclic Indole Alkaloids

Pentacyclic carbazole derivatives Xiamicyn A (186) and B (187) were isolated from different endophytic Streptomyces sp. Compound 186 was an anti-HIV agent [39], while compound 187 exhibited potent antibacterial properties (Figure 43) [122].
Fusaindoterpenes A (188) and B (189), extracted from a culture of Fusarium sp. L1, showed interesting antiviral activity against the Zika virus with EC50 values of 12 and 7.5 μM, respectively. The structure–activity relationship study of these compounds revealed that the cyclopentane-pyrrole fused ring is essential for higher antiviral activity [130].
Penerpenes A–B (190,191) are two indole diterpenoids obtained from Penicillium sp. KFD28, isolated from a bivalve mollusk. Both compounds displayed inhibitory activities against PTPs, becoming a promising target for drug discovery against diabetes [131,132].
Shearinines D and E (192,193) were isolated from the marine-derived strain of the fungus Penicillium janthinellulm Biourge [131]. Both compounds exhibited varied bioactivity, such as the induction of apoptosis in the human leukemia cell line HL-60 [131], as well as inhibition against Candida albicans biofilm formation [132].
Spirocyclic Citrinadin B (194) was extracted from Penicillium citrinum, obtained from a red alga, and showed cytotoxic activity against murine leukemia L1210 cells [133].
Triaza-spirocyclic Meleagrins B–E (195198) were isolated from the fungus Penicillium sp. and showed cytotoxicity against HL-60, MOLT-4, A549, and Bel-7402 cell lines. The bioactivity increases with the complexity of the Meleagrins, being lower for D and E than for B and C [134,135].
Penitrem derivatives (199201) were isolated from the marine-derived fungus Penicillium commune and Aspergillus nidulans EN-330. Compound 199 showed significant anti-invasive and antiproliferative activity against MCF-7 and MDA-MB-231 tumor cell lines [136]. The other two Penitrems exhibited antimicrobial activity [137].
Asperindoles A (202) and Ascandinine D (203) are indolediterpenes with the same structural scaffold obtained from the culture of two different Aspergillus sp. Compound 202 exhibited toxicity against 22Rv1 (induction of cellular apoptosis), PC-3, and LnCaP prostate cancer cell lines [138], while 203 was active against the HL-60 (promyelocytic leukemia) cell lines [139].

2.2.5. Ergot Alkaloids

Pibocins A and B (204205) and Fumigaclavine A (206) are examples of Ergot alkaloids with interesting bioactivity (Figure 44). Pibocins were isolated from ascidian Eudistoma sp. [140] and were found to have antimicrobial and cytotoxic effects against mouse Ehrlich carcinoma cells [140,141]. Compound 206 was extracted from the fungus Aspergillus fumigatus [142] and induced apoptosis in MCF-7 breast cancer cells [143].

2.3. Annelated Indole Alkaloids

Within this subsection, alkaloids containing a single indole core fused with no prenyl-derived (hetero)cyclic ring systems are disclosed (Figure 45).

2.3.1. Quinazoline(inone)-Containing Annelated Indole

Aspertoryadins F and G (207208) contain a 2-indolone moiety linked to a quinazolinone ring through a five-membered spiro lactone. Both compounds were extracted from Aspergillus sp. from a bivalve mollusk. They exhibited quorum sensing (QS) inhibitory activity against Chromobacterium violaceum CV026, causing skin infections. These compounds prohibited bacterial pathogenicity [142].
Fumigatoside E (209) was obtained from Aspergillus fumigatus SCSIO 41012 and showed moderate to strong antibacterial and antifungal activity, with LC50 values of 6.25 μM, against A. baumannii 15,122 and S. aureus ATCC 16,339, and 12.5 μM against A. Baumannii ATCC 19,606 and K. pneumoniae ATCC 14,578. Strong activity against F. oxyosporum f. sp. (LC50 = 1.56 μM) was also observed [144].
Fumiquinazoline J (210) was isolated from the fungal strain Aspergillus fumigatus H1-04 and exhibited cytotoxicity against the cell lines ts FT210, P388, HL-60, A549, and Bel-7402 [143].
Cottoquinazoline D (211), obtained from the marine-derived fungus Aspergillus versicolor, was reported to show antifungal activity against C. albicans [145,146].
Scequinadoline A (212) and Scedapin C (213) contain an imidazoindolone ring and were isolated from an extract of the soft coral-associated fungus S. apiospermum F41-1. Both compounds displayed significant anti-HCV activity against the J8CC recombinant [147].

2.3.2. Imidazolone-Containing Pyrrolidinone

Securamines H and I (214216) are hexacyclic annelated indole alkaloids isolated from the bryozoan Securiflustra securifrons that showed potent cytotoxicity against A2058, HT-29, and MCF-7 lines (Figure 46) [148].

2.3.3. β-Carbolines

β-Carboline alkaloids (βCs) are a tryptophan-derived family of natural products whose basic structure derives from the tricyclic 9H-pyrido[3,4-b]indole (Figure 47). Although initially discovered in plants, a wide range of these compounds have been isolated over decades from marine sources, such as tunicates [149], sponges [150], and bryozoans [151]. βCs display a wide range of outstanding biological activities and, to the best of our knowledge, several plant-isolated and synthetic representative examples, depicted in Figure 47, have been approved by the FDA and commercialized as drugs at some point, including Taladafil [152] and Yohimbine [153] for treating erectile dysfunction, Reserpine [154], Deserpidine [155] and Rescinnamine [156] for treating hypertension, Abecarnil [157] as an anxiolytic, and Cipargamin [158] as an antimalarial.
However, no example of a marine-derived βC has been approved by the FDA, to the best of our knowledge. This is quite surprising since, as will be showcased in the next subsections, they can exert a wide variety of biological activities, such as anticancer, antibiotic, antiplasmodial, anti-inflammatory, and antifungal, among others.
βCs can be found in nature in a monomeric or dimeric fashion [159]. However, some of them are hybrid structures with two different βC cores. Therefore, monomers and dimers will be disclosed in separate subsections and, attending to the absence or presence of extra fused rings in the basic βC skeleton, monomers will be subsequently grouped as ‘simple’- and annelated-βCs.

β-Carboline Monomers

  • ‘Simple’ β-Carbolines
Regarding the saturation of the indole-fused pyridine ring, these compounds can be classified as β-carbolines (βCs), dihydro-β-carbolines (DHβCs), and tetrahydro-β-carbolines (THβCs). It is worth mentioning that the N-methyl quaternary salt of β-carboline alkaloids also occurs in nature.
The simplest β-carboline, Norharmane (217), first isolated from a higher plant, can be found in different marine sponges (Figure 48). In 2007, Herraiz et al. showed that 217 has possible applications against PD [160].
The presence of substituents in the basic structure of βC, and the level of reduction of the ring, lead to enhanced or new properties in comparison with 217. The rest of the section has been structured according to the substituted position in the βC, which is responsible for the therapeutic activity, trying to group them in their corresponding families and making a comparison with their reduced analogs when possible. Therefore, the following subsections will be presented: C1-substituted-βCs, Manzamines, N2-substituted-βCs, and C3-substituted-βCs. It is important to remark that, although manzamines belong to C1-substituted-βCs, their specific structure and bioactivities require a separate discussion from their simpler analogs.

C1-Substituted (DH/TH)β-Carbolines

βCs in which the C1-substitution is responsible for their therapeutic activity represent the largest family of these scaffolds. The variety of functional groups that can be found at C1 is pretty wide, ranging from simple alkyl chains or aryl groups to complex glycosides or polycycles.
Harmane (218) was isolated from the culture of the marine-sponge-associated fungus Neosartorya tsunodae KUFC 9213 [161]. Compound 218 exhibited stronger AChE and BuChE inhibition (IC50 > 10 μM) compared to 217 and weak in vitro antileishmanial activity against Leishmani infantum [162]. 1-Ethyl-β-carboline (219), isolated from the marine bryozoan Orthoscuticella ventricosa, exhibited moderate antiplasmodial activity (IC50 = 18 μM) against the P. falciparum K1 strain [151]. The addition of a C4-OMe to the pyridine ring (220) exerted a detrimental effect on the activity [163]. Other βCs from the same bryozoan, such as 1-ethyl-4-methylsulfone-β-carboline (222), Orthoscuticelline C (223), and Orthoscuticelline D (224), had lower efficiency, indicating that the addition of C4–sulfone to the ring, or hydroxy, amino, or sulfonic acid groups to the alkyl chain, were not beneficial [150,164] (Figure 49).
However, Harmine (221), a C7-OMe analog of 217, first isolated from plants but widely found in marine species, exhibited a wide range of bioactivities, including antitumor, antibiotic, antifungal, antioxidant, antiplasmodial, antimutagenic, and antigenotoxic activity. Further, it acts on gamma-aminobutyric acid type A and the monoamine oxidase A or B receptor, improves insulin sensitivity, exerts vasorelaxant effect, and suppresses osteoclastogenesis, among others. These properties have been well documented by Patel and coworkers [164].
Eudistalbin A (225), isolated from a tunicate Eudistoma album, presented in vitro cytotoxicity (IC50 = 3.2 μg/mL) against KB cells [149]. Plakortamine A (226), isolated from the sponge Plakortis nigra, showed antitumor activity against the HCT-116 cell line (IC50 = 3.2 μM) [150]. Both Eudistomidin C (227) and J (228), obtained from tunicate Eudistoma glaucus [165], have potent cytotoxicity against murine leukemia L1210 cells (IC50 = 0.36 and 0.047 μg/mL, respectively) [165,166], while only 228 is active against P388 and KB cancer cells (IC50 = 0.043 and 0.063 μg/mL, respectively) [166]. 14-Methyleudistomidin C (229), from the ascidian Eudistoma gilboverde, demonstrated significant cytotoxicity against four different human tumor cell lines (IC50 < 1.0 μg/mL) [167]. Ingenine E (230), isolated from the sponge Acanthostrongylophora ingens, is strongly cytotoxic against MCF-7, HCT-116, and A549 lines [168]. It is worth mentioning that, although Orthoscuticelline C (222) is chemically similar to 215228, its anticancer biological activity has not been tested so far.
Opacalines A (231) and B (232), found in the ascidian Pseudodistoma opacum, exhibited antiplasmodial activity due to alkyl guanidine-substituted chains (IC50 = 2.5 and 4.5 μM, respectively) [169]. As observed, the N9-hydroxylation reacts negatively to this activity. Other synthetic debromo- or THβCs derivatives of 231 and 232 were less active than the parent compounds, indicating that the Br atom plays an important role in the activity.
Eudistomins W (233) and X (234), isolated from tunicate Eudistoma sp., have antifungal activity against C. albicans and B. subtilis, S. aureus, and E. coli, respectively, as well as some antibiotic properties [170].
Imidazolium-containing Gesashidine A (235), first isolated from a Thorectidae sponge, showed antibacterial activity against Micrococcus luteus but no cytotoxicity against the cell line L5178Y [171]. Interestingly, the presence of a C3-carboxylate shuts down the antibacterial activity of Dragmacidonamine A (236), isolated from the same sponge, and its sulfoxide Hyrtimomine H (237), obtained from Hyrtios sponge. However, it enhances their cytotoxicity when compared to 235 (Figure 49).
Reduced DHβC and THβC analogs of compounds 217237 (Figure 50) have similar therapeutic activity compared to their unsaturated counterparts. Eudistomidins B (238), G (239), H (240), and I (241), isolated from Eudistoma glaucus, exhibited cytotoxicity against L1210, L5178Y, P388, and KB cancer cells, although weaker than related compounds 223237. Ingenine F (242), obtained from Acanthostrongylophora ingens, showed similar levels of cytotoxic activity against MCF-7, HCT-116, and A549 lines compared to compound 230 [172]. (+)-7-Bromotrypargine (243), isolated from the marine sponge Ancorina, exerts antimalarial activity similar to 231, but also weak cytotoxicity against HEK293 cells [173]. Haploscleridamine (244), isolated from Haplisclerida sponge, was identified as an inhibitor of cathepsin K [174], while its C3-CO2H analog Hainanerectamine C (245), identified from the Hyrtios erecta sponge, showed moderate anticancer activity as an inhibitor of Aurora kinase A [35].
Hyrtimomine I (246) and J (247), hydroxyimidazolium βCs found in the Hyrtios sponge, exhibited antifungal activity against A. niger (IC50 = 8.0 μg/mL each) and C. albicans (IC50 = 2.0 μg/mL each), but only 246 showed activity against C. neoform (IC50 4.0 μg/mL). However, Hyrtimomine H (248), from the same sponge, showed no activity, indicating that the C3-CO2H group is crucial [175] (Figure 51). It is worth noting that this kind of activity has not been reported so far for similar compounds 235237.
Blunt and Munro indicated that C1-vinyl groups might be beneficial for antitumor activity (Figure 52). 1-Vinyl-8-hydroxy-β-carboline (249), collected from bryozoan Cribricellina cribaria [176], and Plakortamine B (250), produced by the sponge Plakortis nigra [150], were found to be active against the P388 (IC50 = 100 ng/mL) and HCT-116 cell lines (IC50 = 3.2 μM), respectively. The C1-aryl compound Chaetogline F (251), obtained from the fish-derived fungus Chaetomium globosum 1C51 through biotransformation [177], represents a more promising structure for the design of anti-Alzheimer’s drugs [178] and had antibiotic activity against Veillonella parvula, Bacteroides vulgatus, Streptococcus sp., and Pepto streptococcus sp. [179]. Apart from antibiotic activities, other authors found that some synthetic C1-aryl derivatives exhibited activity against Leishmania donovani [180].
C1-furyl-substituted Flazin (252) (Figure 53), obtained from the oyster Crassostrea sikamea [181], is a promising candidate for the development of anti-HIV drugs [182]. An exhaustive SAR study carried out by Liu et al. identified the synthetic Flazinamide (253) as the most promising drug. Eudistomin I (254), isolated from Eudistoma olivaceum tunicate, contains a dihydropyrrole ring that confers its antibacterial effects [183,184,185]. Indole-substituted Eudistomin U (255) and Isoeudistomin U (256), isolated from Lissoclinum fragile, and their synthetic analogs, have been reported to have antibacterial, antimalarial, and anticancer properties, as extensively reviewed by Kolodina and Serdyuk [186]. Plakortamine D (257), a C1-isoxazolidine-substituted scaffold obtained from the Plakortis nigra sponge, has antitumor activity against the HCT-116 cell line (IC50 = 15 μM) [150]. Finally, Annomontine (258), Ingenine C (259), and Ingenine D (260), all of them bearing aminopyrimidine rings and isolated from the Indonesian sponge Acanthostrongylophora ingens, exhibited cytotoxic activities against MCF-7 and HCT-116 [168,187].
1-Acetyl-β-carboline (261), isolated from Marinactinospora thermotolerans, showed weak cytotoxicity against NCI-H460 cells (IC50 = 18.73 μg/mL) [188] and antibiotic properties against S. aureus [189]. Eudistomidin K (262), from the tunicate Eudistoma glaucus, exhibited weak cytotoxicity against P388, L1210, and KB cells (IC50 > 10.0 μg/mL) [166]. Marinacarbolines A–D (263266), obtained from Marinactinospora thermotolerant, and their synthetical derivatives, bear an additional C3-amido moiety with pendant aryl rings (Figure 54). Their cytotoxicity was first investigated in 2015 [190], but Hong and Lee have performed a very recent and in-depth SAR study against ocetaxel-Resistant Triple-Negative Breast Cancer [191]. Compounds 263266 also exhibit promising antimalarial activity [129]. Eudistalbin A (267), isolated from Eudistoma album tunicate, exerts cytotoxic activity in vitro against KB cells (IC50 = 3.2 μg/mL) [149]. Eudistomin T (268), from the tunicate Eudistoma olivaceum, exhibited not only weak phototoxicity but also antibiotic properties [184].
Eudistomin Y (269), isolated from Eudistoma tunicates, and its synthetic analogs, tends to exhibit antifungal [192] and antibiotic [192,193] properties (Figure 55), but also significant cytotoxic and antiproliferative activities [192,194,195]. SAR analysis indicated that an increased number of Br atoms in the aromatic rings increased their antibiotic effect. Reduction of the benzoyl moiety does not affect its properties, as found for Eudistomin Y11 (270).
Xestomanzamine A (271) (Figure 56), isolated from the sponge Acanthostrongylophora sp., had moderate antibiotic, anti-HIV, and antifungal activity, but no cytotoxicity against A594 and HCT-116 [196]. However, imidazole-containing Hyrtiocarboline (272), from Hyrtios reticulatus sponge, showed significant cytotoxicity against H522-T1, MDA-MB-435, and U937 cell lines (IC50 = 1.2, 3.0, and 1.5 μg/mL, respectively) [197]. Imidazolium-containing Hyrtiomanzamine (273), from Hyrtios erecta sponge, and Dragmacidonamine A (274), from Dragmacidon sponge, exhibited some cytotoxicity [171,197]. Further, 273 exhibited some immunosuppressive activity [198]. Indolyl-substituted Pityriacitrin (275), first isolated from a Paracoccus marine bacterium, exerts promising anticancer activity against MCF-7, MDA-231, and PC3 cell lines [199]. In-depth SAR analysis of Pityriacitrin analogs showed that C3 amide, hydrazide, hydrazones, 1,3,4-oxadiazole, 1,2,4-triazole, and pyrazole moieties are essential for potent anticancer activity [200].
Hyrtiosulawesine (276), found in the Indonesian sponge Hyrtios erectus, displays a great variety of properties, such as antioxidant [201], antiphospholipase A2 [202], antidiabetic [203], anti-inflammatory [204], antimalarial [205], and cytotoxicity properties, towards the Hep-G2 cell line (IC50 = 19.3 μmol/L) [206]. 6-O-(β-glucopyranosyl)hyrtiosulawesine (277), from the same marine species, is only slightly cytotoxic towards hepatic cells and has antimalarial activity (IC50 = 5 μM).
Finally, Shishijimicin A–C (278280) (Figure 57), isolated from sea squirt Didemnum proliferum, has antitumor activity against P388 cells [207]. This property is attributed to the intricate and conjugated enediyne functional group, with 278 being the most powerful enediyne-based antitumor and antibiotic identified to date. Remarkably, the total synthesis of compound 278 was accomplished in 2015 by Nicolaou [208].

Manzamines

Manzamines are a special family of C1-substituted βCs in which the C1 moiety generally consists of a characteristic complex penta-or tetracyclic system or a monomacrocycle (Figure 58). Manzamine A (281) (also named Keramamine A) [209] was the first reported member of these compounds [210]. Compound 281 showed a broad spectrum of biological effects, including potent antileishmanial and antimycobacterial activity [211], cytotoxicity against pancreatic cancer, P388, and human colorectal carcinoma [210,212,213], and anti-Alzheimer’s activity [214]. It also exhibited antiviral effects against HSV-1, HSV-2, and HIV [211,215,216]. Compound 281 exhibited potent antitubercular activity against M. tuberculosis (H37Rv) [217]. 8-Hydroxymanzamine A (282) (also named manzamine G or manzamine K) exhibited moderate antitumor activity against KB and LoVo lines and anti-HSV-2 activity [216]. ent-8-Hydroxymanzamine A (283) is active against P388 (IC50 = 0.25 µg/mL) and exerts an in vitro antitrypanosomal effect [218]. Manzamine M (284) had cytotoxicity against L1210 cells (IC50 = 0.3 µg/mL), and antibacterial activity against Sarcina lutea (MIC = 2.3 µg/mL) and Corynebacterium xerosis (MIC = 5.7 µg/mL) [219].
12,34-Oxamanzamine A (285), with a C12–C34 ether bridge, exhibited lower antimalarial and antituberculosis activity compared to the other manzamines [220]. 12,28-Oxamanzamine A (286) and 12,28-Oxa-8-hydroxymanzamine A (287), with C12–C28 or C12–C34 ether bridges, showed effective antifungal, anti-inflammatory and anti-HIV-1 activities [221].
3,4-Dihydro-6-hydroxymanzamine A (288) had cytotoxicity against L1210 cells (IC50 = 1.4 µg/mL), and antibacterial activity against Sarcina lutea (MIC = 6.3 µg/mL) and Corynebacterium xerosis (MIC = 3.1 µg/mL) [219]. N-Methyl-epi-manzamine D (289) and epi-Manzamine D (290) showed cytotoxicity against HeLa and B16-F10 cells [220]. 1,2,3,4-Tetrahydro-2-N-methyl-8-hydroxymanzamine A (291) (8-Hydroxy-2-N-methylmanzamine D) is cytotoxic toward the P388 cell line (ED50 = 0.8 µg/mL) [222].
Biologically active pentacyclic manzamines having a ketone or alcohol group in their eight-membered ring instead of a double bond, have been also reported (Figure 59). Manzamine E (292) and Manzamine F (Keramamine B) (293) displayed cytotoxicity toward L5178Y and P388 cells [223]. Ent-manzanine F (294) inhibited H37Rv (IC50 < 12.5 µg/mL) [218]. ent-12,34-oxamanzamines E (295) and F (296) showed weak inhibitory activity against M. tuberculosis (IC50 value of 128 µg/mL) [220]. Pre-neo-kauluamine (297) exhibited proteasome inhibitory activity, a potent antitrypanosomal effect, and antimalarial activity [224,225].
Several biologically active manzamines containing a βC ring system with a C1-tetracyclic scaffold have been reported (Figure 60). Manzamine J (298) showed cytotoxic activity against KB cells (IC50 > 10 µg/mL), while its N-oxide (299) showed cytotoxicity against L1578Y (IC50 = 1.6 µg/mL). Additionally, 298 has anti-tubercular activity against H37Rv [217]. Manzamine B N-oxide (300) displayed weak activity against several Gram-positive and Gram-negative bacteria [226]. Acanthomanzamines D (301) and E (302), had a strong proteasome inhibitory effect (IC50 = 0.63 and 1.5 µg/mL, respectively) [227].
Manzamines H (303) and L (304) hold cytotoxicity against KB cells (IC50 = 4.6 and 3.5, respectively). Compound 304 also possesses weak activity antibiotic activity [226]. Ma’eganedin A (305), proved to be a potent antibiotic against Sarcina lutea and B. subtilis (MIC = 2.8 µg/mL each) [228].
Furthermore, 3,4-Dihydromanzamine J (306), and all the aforementioned manzamines, 291, 303305, showed cytotoxic activity against the L1210 cell line (IC50 = 5.0, 2.6, 1.3, 3.7, and 4.4 µg/mL, respectively) [217].
Finally, other types of monomacrocyclics and diverse hexa- and heptacyclic biologically active manzamines have been reported (Figure 61). Manzamine C (307) exhibited cytotoxicity against A549, HT-29, and P388 cells (IC50 = 3.5, 1.5, and 2.6 μg/mL, respectively) [229]. Pyrrolizine-substituted Kepulauamine A (308) unveiled weak inhibition against K562 and A549 cells and moderate antibiotic activity [226]. Manzamine X (309) exhibited cytotoxic activity against KB cells (IC50 = 7.9 μg/mL) [230], while 6-Deoxymanzamine X (310) exhibited cytotoxicity against L5178 cells (ED50 = 1.8 µg/mL) [231]. Manadomanzamines A (311) and B (312) exhibited an anti-tubercular effect (MIC = 1.9 and 1.5 µg/mL, respectively), antiviral activity against HIV-1 (EC50 = 7.0 and 16.5 µg/mL, respectively), cytotoxicity against A549 (IC50 = 2.5 µg/mL, only 311) and HCT-116 cells (IC50 = 2.5 and 5.0 µg/mL, respectively), and an antifungal effect against C. albicans (MIC = 20 µg/mL, only 312) and C. neoformans (MIC = 3.5 µg/mL, only 311) [196].

N2-Substituted (DH/TH)β-Carbolines

The N2-methyl-β-carbolinium salts Irene-carbolines A (313) and B (314), isolated from ascidian Cnemidocarpa irene, exerted anti-Alzheimer’s activity [232] (Figure 62). Notably, other non-brominated derivatives identified in the same species did not exhibit any activity.
The N2-aryl-β-carbolinium species Reticulatol (315), Reticulatine (316), and Reticulatate (317) could be obtained from Fascaplysinopsis reticulata sponge. Compounds 316 and 317 had modest antitumor activity, while 315 showed significant selectivity for leukemia [233].

C3-Substituted (DH/TH)β-Carbolines

Variabines A (318) and B (319), with a C3-ester (Figure 63), were isolated from the sponge Luffariealla variabilis, and had a respectively little and significant effect on the inhibition of the chymotrypsin-like activity of proteasome and breast cancer metastasis [234]. Therefore, the inhibitory activities are lost by sulfonation of the 6-OH group. Stolonine C (320), from the tunicate Cnemidocarpa stolonifera, induced apoptosis in the PC3 cell line [235]. Tiruchanduramine (321), obtained from the ascidian Synoicum macroglossum, could be identified as a promising inhibitor of α-glucosidase due to the presence of a cyclic guanidine group [236].
C3-indole-substituted βCs have been also found in marine sources, such as the family of Hyrtioerectines isolated from the sponge Hyrtios erectus. Hyrtioerectine A (322) showed moderate cytotoxicity against HeLa cells (IC50 = 10 μg/mL) [237]. Hyrtioerectines D–F (323325) exhibited antibacterial behavior against C. albicans, S. aureus, and Pseudomonas aeruginosa. They also exhibited antioxidant activity, and weak antitumor activity against MDA-MB-231, A549, and HT-29 cell lines, with 323 and 324 being more active than compound 325. Therefore, the methylation of the phenol group hampers the antioxidant activity, while a C4-CO2H moiety is more beneficial than an amido group for antitumor properties.
Regarding saturated carbolines (Figure 64), Hyrtioerectine B (326) prompted moderate cytotoxicity against HeLa cells (IC50 = 5.0 μg/mL).

Annelated β-Carbolines

Several βCs with different 5-, 6- or 7-membered fused rings in different positions have been isolated from marine sources over decades, and some of them exhibited promising activities (Figure 65). Fascaplysin (327), 3-Bromofascaplysin (328), 10-Bromofascaplysin (329), 3,10-Dibromofascaplysin (330), 6-Oxofascaplysin (331), and Homofascaplysate A (332) are pentacyclic compounds isolated from the sponge Fascaplysinopsis sp., in which the βC core is fused to a 5-membered ring through C1 and N2. In general, Fascaplysin natural and synthetic derivatives represent excellent lead drugs since they exert multiple activities. Namely, anticancer activity against Human Alveolar Rhabdomyosarcoma cells, leukemia, liver cancer cells, melanoma, small lung cancer cells, and ovarian cancer cells, among others. Further, they also exert analgesic, anti-thrombotic, anti-Alzheimer’s, and antimalarial activity [238]. Thorectandramine (333), from the marine sponge Thorectandra sp., had weak cytotoxicity against MCF-7, OVCAR-3, and A549 cell lines (EC50 27.0–55.0 μg/mL) [239].
Eudistomins C (334), E (335), K (336), and L (337), Eudistomin K sulfoxide (338) and Debromoeudistomin K (339) are tetracyclic THβC isolated from different marine ascidians, featuring a fused oxathiazepine ring between C1 and N2, responsible of their antiviral activity against HSV-1 and other DNA- or RNA-viruses [183]. Additionally, 336 has potent antitumor activity against L1210, A549, HCT-8, and P388 cell lines [240].
Hyrtimomines D (340) and E (341), which contain a fused D-ring between C1 and N9 forming a lactam unit, belong to the canthin-6-one family (Figure 66). Both have antifungal activity against C. albicans (IC50 = 4 and 8 μg/mL, respectively) and C. neoformans (IC50 = 4 and 8 μg/mL, respectively), but only 340 showed inhibitory activity against T. mentagrophytes (IC50 = 16 μg/mL) and S. aureus (IC50 = 4 μg/mL). From their results, the authors inferred that the presence of carboxylic acid is less beneficial for its antifungal properties [175].

β-Carboline Dimers

Some recent research has shown a potential trend in which the dimers tend to be more active than the corresponding monomers [159]. Therefore, several authors have turned their attention toward the synthesis and evaluation of these scaffolds. According to the linked positions of the βC monomers, they can be divided into 1,1-, 2,2-, 3,3-, 9,9-linked, and ‘hybrid’ dimers, in which the two βC units are not equivalent.
However, these structures are not that commonly found in marine species compared to plants and, to the best of our knowledge, only a couple of marine-isolated or marine-inspired synthetic dimers with biological activity have been reported to date.

1,1-Linked Dimers

As far as we can ascertain, only three examples of biologically active marine naturally occurring 1,1-dimers have been reported to date, varying the nature of the organic linker from simple alkyl chains to complex polycyclic structures (Figure 67). Orthoscuticellines A (342), a dimer derived from Plakortamine B (250) and obtained from the bryozoan Orthoscuticella ventricosa, has a 1,2-cyclobutane unit as a linker. Although its trans dimer had no activity, 342 demonstrated higher cytotoxicity than parent 250 and moderate antiplasmodial activity [151]. Plakortamine C (343), which can be regarded as a Plakortamine A (226) dimer and was isolated from the same Plakortis nigra sponge, exhibited higher cytotoxic activity than 226 against the HCT-116 cell line (IC50 = 2.15 mM) [150]. Finally, the manzamine 1,1-dimer Neo-kauluamine (344), isolated from Indonesian Acanthostrongylophora ingens sponge, exhibited potent cytotoxic activity against H12999 (IC50 = 1.0 mM), proteasome inhibitory activity (IC50 = 0.13 mM), and the inhibition of the accumulation of cholesterol esters [224].
It is worth mentioning that, inspired by these structures, Chatwichien et al. developed the synthesis of 1,1-dimers of simple Norharmane (217) linked by aminoalkylether chains [241]. Surprisingly, their biological activity against various cancer cell lines was as good as the one exerted by Neo-kualamine (344). Given the potential of these compounds, this area is still a hot topic of research with promising expectations.

9,9-Linked Dimers

Interestingly, an N–N bonded 9,9-dimer of Norharmane (217) was isolated from the Didemnum sp. ascidian (Figure 68). Although this species’ antibiotic activity was diminished in comparison to 217, other synthetic derivatives have a wide application. In fact, the double N-methylated carbolinium salt (345) was found to be more active for some strains such as S. aureus [242].

‘Hybrid’ Dimers

Some manzamine derivatives, in particular in the family of Zamamidines, were found to bear a second pendant βC unit, usually exhibiting an N2–C1′ linkage (Figure 69). Zamamidine C (346) demonstrated a potent antitrypanosomal effect against Trypanosoma brucei brucei and antimalarial activity against P. falciparum [225]. Zamamidines A (347) and B (348) displayed cytotoxic activity against P388 cells (IC50 = 13.8 and 14.8 µg/mL, respectively) [217].
Finally, an interesting example of a 1,1′-hybrid manzamine dimer Kauluamine (349), isolated from the sponge Prianos sp. (Figure 70), revealed moderate immunosuppressive effect in a mixed lymphoma reaction [243].

General Syntheses of β-Carboline Alkaloids

Within the last decade, the synthesis of βCs has been quite extensively reviewed from diverse perspectives, focusing on the construction of the 9H-pyrido[3,4-b]indole [244]. Some of these authors distinguished between classical and current approaches, and a brief summary of each is provided below.
Classical routes, summarized in Figure 71 and Figure 72, are mostly dominated by the use of acid-/base-catalyzed or photochemical metal-free approaches. The most commonly exploited synthetic route for the formation of the βCs core, even nowadays, is the Pictet–Spengler reaction (Figure 71, method A) [245], starting from readily available tryptophan derivatives and carbonyl compounds. Another variation of this method includes the in situ reduction of nitriles (Figure 71, method B) [246]. A third variation of this methodology is the Bilschler–Napieralski reaction (Figure 71, method C) [247], in which amido-trypthophan derivatives are converted to electrophilic chlorimines using P2O5 or POCl3. All three routes yield tetrahydro-βC derivatives (THβCs), which require further oxidation steps to generate dihydro-βC (DHβC) or βCs. An important feature of the Pictet–Spengler approach for the synthesis of saturated carbolines is the possibility of inducing chirality by employing enantioselective aid catalysts [245].
Other early works reported the synthesis of βCs from 3-vinylindoles (Figure 72, method A) [248], Diels–Alder reactions (Figure 72, method B) [249], the Pd-catalyzed intramolecular arylation of anilinobromopyridines (Figure 72, method C) [250], Graebe–Ullmann reactions (Figure 72, method D) [251], the intramolecular nucleophilic substitutions of anilinofluoropyridines (Figure 72, method E) [252], and the photocyclization of anilinopyridines (Figure 72, method F) [253]. However, some of these procedures lacked functional group tolerance, forming only simple βC structures.
Over the past two decades, the number of chemical tools for organic synthesis has grown exponentially and, given the promising application of βCs as a drug, several new methodologies have been developed to build its azacarbazol skeleton. Mordi and Arshad performed an extensive review of these new methodologies [254], grouping them into the following categories: Larock heteroannulation (Figure 73A), C-H activation reactions (Figure 73B), Cycloaddition reactions (Figure 73C), 6π-Electrocyclizations (Figure 73D), Electrophilic cycloaromatization (not reported for βC so far), Cross-coupling reactions (Figure 73E), and Radical nucleophilic substitution (Figure 73F). Summarizing all of these processes is a difficult quest, given the wide range of chemical structures that could be potential starting materials and the transformations reported. Therefore, only one example of each is represented in Figure 73.
In this scenario, the elaboration of these scaffolds remains a hot area of research, although classical approaches are still preferred in most drug discovery programs. Notably, the development of valuable synthetic intermediates through these methodologies has allowed us to also explore a great number of further derivatization processes [255].

2.3.4. Other Annelated Indole Alkaloids

In this section, some examples of annelated indole alkaloids (350354), with varied structures, have been included due to their cytotoxic activity against several human cancer cell lines (Table 2).

3. Conclusions

Marine Indole Alkaloids comprise a wide variety of families of compounds. They originate from numerous marine organisms, such as fungi, sponges, corals, and mollusks, among others. As they are compounds released in order to survive against pathogens/predators in their own natural environment, they have important biological and pharmacological properties, such as antibacterial (potentially interesting to combat resistance from hospital bacteria) and anticancer (to avoid the resistance that some patients develop against certain therapies). Likewise, they have been shown to be potentially useful for treating certain eating disorders and diabetes. In this sense, MIAs can be considered as potential MDR modulators and/or sources of promising lead compounds, as demonstrated by the antibacterial and anticancer properties of some MIAs shown in this review. However, despite these promising applications, around 86% of MIAs’ potential remains largely underexplored, probably due to the absence of a systematic approach for exploring their pharmacological activity at clinically relevant concentrations for drug discovery. To harness the full therapeutic potential of MIAs, it is imperative to develop new bioassay techniques and synthetic protocols. These innovations would enable the precise interrogation of MIAs and facilitate their straightforward modification to enhance pharmacological efficacy. Although some MIAs may initially exhibit biological inactivity, strategic chemical modifications hold promise for optimizing their pharmacological properties. We believe that these approaches could represent a critical advancement in the quest for novel therapies to address current and emerging diseases, particularly in the face of challenges posed by antibiotic-resistant superbugs and therapy-resistant cancers.

Author Contributions

Conceptualization and resources, Y.A.; writing—original draft preparation, Y.A., S.F., V.A. and D.R.; writing—review and editing, Y.A. and S.F. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Acknowledgments

S. Fernández thanks the “Fundación Ramón Areces” for a Postdoctoral Fellowship (BEVP34A6835) and United Kingdom Research and Innovation (UKRI) for a Postdoctoral Guarantee Scheme Fellowship (MSCA) (EP/Y027612/1). V. Arnáiz thanks the project funded by Ministerio de Ciencia e Innovación (CP23/126). Likewise, D. Rufo thanks the grant funded by Ministerio de Educación y formación professional (23C01/001602).

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

AbbreviationMeaningAbbreviationMeaning
5-HT5-hydroxytryptamine receptorsHIVHuman Immunodeficiency Virus
5-HT2AHydroxytryptamine 2AHL-60Promyelocytic leukemia cell line
5-HT2C5-Hydroxytryptamine 2CHSVHerpes Simplex Virus
A/WSN/33
(H1N1)
Influenza A Virus Subtype H1N1HT-29Human colon cancer cell line
A549Adenocarcinomic human alveolar basal epithelial
cell line
IC50Half-Maximum Inhibitory Concentration
AChEAcetylcholinesteraseK562Human myelogenous leukemia cell line
B16-F10Melanoma cell lineKBHuman epithelial carcinoma cell line
βCβ-CarbolineL1210Mouse lymphocytic leukemia cell line
BCGBacille Calmette-GuérinL5178YMouse lymphoma cell line
BChEButyrylcholinesteraseLMM3Human Melanoma Cells
CK1δCasein Kinase 1 DeltaLoVoHuman colorectal cancer cell lines
CLK1CDC-like Kinase 1MCF-7Human breast cancer cell line
DCE1,2-DicloroetaneMDA-MB-231Human Metastatic Breast Carcinoma Cells
DCMDichloromethaneMDA-MB-435Human Breast Carcinoma Cell line
DHβCDihydro- β-CarbolineMDCKMadin-Darby canine kidney
DKPDiketopiperazineMICMinimum Inhibitory Concentration
DMAN,N-DimethylacetamideMRC-9Human lung cancer cell line
DMAPPDimethylallyl pyrophosphateMRSAMethicillin-Resistant Staphylococcus aureus
DMFN,N-DimethylformamideNCI-H460Human non-small cell lung carcinoma cell line
DPPH2,2-Diphenyl-1-picrylhydrazylNFκBNuclear Factor κB
Dyrk1ADual-Specificity Tyrosine-Phosphorylation
Regulated Kinase 1A
OVCAR-3Human high-grade serous ovarian adenocarcinoma cell line
ED50dose of a medication that produces the intended pharmacological effect in 50% of the patient population studiedP388Leukemia cell line
FDAFood and Drug AdministrationPC3Human prostatic adenocarcinoma cell line
GSK-3βGlycogen Synthase Kinase
3 Beta
PDParkinson’s Disease
H12999Human non-small cell
lung carcinoma cell line
PIAPrenylated Indole Alkaloid
H37RvMycobacterium tuberculosis strainPPiPyrophosphate
H522-T1human non-small cell lung cancer cell linePTPProtein Tyrosine Phosphatase
HCT-116Human colon cancer cell lineRDHuman Rhabdomyosarcoma Cells
HCT-8human colon carcinoma
cell line
SIASimple Indole Alkaloid
HEK293Human Embryonic Kidney cell lineTHβCTetrahydro-β-Carboline
HEK293 T9Non-malignant human kidney cell lineTHFTetrahydrofuran
HeLaHuman Cervical Epidermoid Carcinoma CellsU937Human histiocytic lymphoma cell line
Hep2Human Epithelial Carcinoma CellsUSF-HO25University of South Florida-Human Osteosarcoma 25
Hep-G2Human hepatocellular carcinoma cell lineUVUltraviolet

References

  1. Karthikeyan, A.; Joseph, A.; Nair, B.G. Promising Bioactive Compounds from the Marine Environment and Their Potential Effects on Various Diseases. J. Genet. Eng. Biotechnol. 2022, 20, 14–52. [Google Scholar] [CrossRef]
  2. Carroll, A.R.; Copp, B.R.; Davis, R.A.; Keyzers, R.A.; Prinsep, M.R. Marine Natural Products. Nat. Prod. Rep. 2023, 40, 275–325. [Google Scholar] [CrossRef]
  3. Zhang, L.; An, R.; Wang, J.; Sun, N.; Zhang, S.; Hu, J.; Kuai, J. Exploring Novel Bioactive Compounds from Marine Microbes. Curr. Opin. Microbiol. 2005, 8, 276–281. [Google Scholar] [CrossRef]
  4. Malve, H. Exploring the Ocean for New Drug Developments: Marine Pharmacology. J. Pharm. Bioall. Sci. 2016, 8, 83–91. [Google Scholar] [CrossRef]
  5. Xu, Z.; Eichler, B.; Klausner, E.A.; Duffy-Matzner, J.; Zheng, W. Lead/Drug Discovery from Natural Resources. Molecules 2022, 27, 8280. [Google Scholar] [CrossRef]
  6. Taori, K.; Paul, V.J.; Luesch, H. Structure and Activity of Largazole, a Potent Antiproliferative Agent from the Floridian Marine Cyanobacterium Symploca Sp. J. Am. Chem. Soc. 2008, 130, 1806–1807. [Google Scholar] [CrossRef]
  7. Ying, Y.; Taori, K.; Kim, H.; Hong, J.; Luesch, H. Total Synthesis and Molecular Target of Largazole, a Histone Deacetylase Inhibitor. J. Am. Chem. Soc. 2008, 130, 8455–8459. [Google Scholar] [CrossRef]
  8. Sun, H.; Sun, K.; Sun, J. Recent Advances of Marine Natural Indole Products in Chemical and Biological Aspects. Molecules 2023, 28, 2204. [Google Scholar] [CrossRef]
  9. Walter, T.; Veldmann, K.H.; Götker, S.; Busche, T.; Rückert, C.; Kashkooli, A.B.; Paulus, J.; Cankar, K.; Wendisch, V.F. Physiological Response of Corynebacterium glutamicum to Indole. Microorganisms 2020, 8, 1945. [Google Scholar] [CrossRef]
  10. Huang, Z.; Yin, L.; Guan, L.; Li, Z.; Tan, C. Novel Piperazine-2,5-Dione Analogs Bearing 1H-Indole: Synthesis and Biological Effects. Bioorg. Med. Chem. Lett. 2020, 30, 127654–127658. [Google Scholar] [CrossRef]
  11. Wei, C.; Zhang, J.; Shi, J.; Gan, X.; Hu, D.; Song, B. Synthesis, Antiviral Activity, and Induction of Plant Resistance of Indole Analogues Bearing Dithioacetal Moiety. J. Agric. Food Chem. 2019, 67, 13882–13891. [Google Scholar] [CrossRef]
  12. Li, B.; Yao, J.; Guo, K.; He, F.; Chen, K.; Lin, Z.; Liu, S.; Huang, J.; Wu, Q.; Fang, M.; et al. Design, Synthesis, and Biological Evaluation of 5-((8-Methoxy-2-Methylquinolin-4-Yl)Amino)-1H-Indole-2-Carbohydrazide Derivatives as Novel Nur77 Modulators. Eur. J. Med. Chem. 2020, 204, 112608. [Google Scholar] [CrossRef]
  13. Sreenivasulu, R.; Reddy, K.T.; Sujitha, P.; Kumar, C.G.; Raju, R.R. Synthesis, Antiproliferative and Apoptosis Induction Potential Activities of Novel Bis(Indolyl)Hydrazide-Hydrazone Derivatives. Bioorg. Med. Chem. 2019, 27, 1043–1055. [Google Scholar] [CrossRef]
  14. Diao, P.-C.; Jian, X.-E.; Chen, P.; Huang, C.; Yin, J.; Huang, J.C.; Li, J.-S.; Zhao, P.-L. Design, Synthesis and Biological Evaluation of Novel Indole-Based Oxalamide and Aminoacetamide Derivatives as Tubulin Polymerization Inhibitors. Bioorg. Med. Chem. Lett. 2020, 30, 126816–126822. [Google Scholar] [CrossRef]
  15. Vijayakumar, B.G.; Ramesh, D.; Joji, A.; Jayachandra Prakasan, J.; Kannan, T. In Silico Pharmacokinetic and Molecular Docking Studies of Natural Flavonoids and Synthetic Indole Chalcones against Essential Proteins of SARS-CoV-2. Eur. J. Pharmacol. 2020, 886, 173448–173459. [Google Scholar] [CrossRef]
  16. Hoffman, R.L.; Kania, R.S.; Brothers, M.A.; Davies, J.F.; Ferre, R.A.; Gajiwala, K.S.; He, M.; Hogan, R.J.; Kozminski, K.; Li, L.Y.; et al. Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19. J. Med. Chem. 2020, 63, 12725–12747. [Google Scholar] [CrossRef]
  17. Dong, J.; Wang, T.; Lu, J.; Ding, C.Z.; Hu, L.; Hu, G.; He, H.; Zeng, X.; Li, X.; Sun, D.; et al. Design, Syntheses and Evaluations of Novel Indole Derivatives as Orally Selective Estrogen Receptor Degraders (SERD). Bioorg. Med. Chem. Lett. 2020, 30, 127601–127606. [Google Scholar] [CrossRef]
  18. Miao, G.; Wang, Y.; Yan, Z.; Zhang, L. Synthesis, in Vitro ADME Profiling and in Vivo Pharmacological Evaluation of Novel Glycogen Phosphorylase Inhibitors. Bioorg. Med. Chem. Lett. 2020, 30, 127117–127123. [Google Scholar] [CrossRef]
  19. Solangi, M.; Khan, K.M.; Saleem, F.; Hameed, S.; Iqbal, J.; Shafique, Z.; Qureshi, U.; Ul-Haq, Z.; Taha, M.; Perveen, S. Indole Acrylonitriles as Potential Anti-Hyperglycemic Agents: Synthesis, α-Glucosidase Inhibitory Activity and Molecular Docking Studies. Bioorg. Med. Chem. 2020, 28, 115605–115616. [Google Scholar] [CrossRef]
  20. Méndez, M.; Matter, H.; Defossa, E.; Kurz, M.; Lebreton, S.; Li, Z.; Lohmann, M.; Löhn, M.; Mors, H.; Podeschwa, M.; et al. Design, Synthesis, and Pharmacological Evaluation of Potent Positive Allosteric Modulators of the Glucagon-like Peptide-1 Receptor (GLP-1R). J. Med. Chem. 2020, 63, 2292–2307. [Google Scholar] [CrossRef]
  21. Purgatorio, R.; De Candia, M.; Catto, M.; Carrieri, A.; Pisani, L.; De Palma, A.; Toma, M.; Ivanova, O.A.; Voskressensky, L.G.; Altomare, C.D. Investigating 1,2,3,4,5,6-Hexahydroazepino[4,3-b]Indole as Scaffold of Butyrylcholinesterase-Selective Inhibitors with Additional Neuroprotective Activities for Alzheimer’s Disease. Eur. J. Med. Chem. 2019, 177, 414–424. [Google Scholar] [CrossRef]
  22. Ju, Z.; Su, M.; Hong, J.; La Kim, E.; Moon, H.R.; Chung, H.Y.; Kim, S.; Jung, J.H. Design of Balanced COX Inhibitors Based on Anti-Inflammatory and/or COX-2 Inhibitory Ascidian Metabolites. Eur. J. Med. Chem. 2019, 180, 86–98. [Google Scholar] [CrossRef]
  23. Huang, Y.; Zhang, B.; Li, J.; Liu, H.; Zhang, Y.; Yang, Z.; Liu, W. Design, Synthesis, Biological Evaluation and Docking Study of Novel Indole-2-Amide as Anti-Inflammatory Agents with Dual Inhibition of COX and 5-LOX. Eur. J. Med. Chem. 2019, 180, 41–50. [Google Scholar] [CrossRef]
  24. Bai, H.; Cui, P.; Zang, C.; Li, S. Enantioselective Total Synthesis, Divergent Optimization and Preliminary Biological Evaluation of (Indole-N-Alkyl)-Diketopiperazines. Bioorg. Med. Chem. Lett. 2019, 29, 126718–126723. [Google Scholar] [CrossRef]
  25. Mishra, S.; Kaur, M.; Chander, S.; Murugesan, S.; Nim, L.; Arora, D.S.; Singh, P. Rational Modification of a Lead Molecule: Improving the Antifungal Activity of Indole—Triazole—Amino Acid Conjugates. Eur. J. Med. Chem. 2018, 155, 658–669. [Google Scholar] [CrossRef]
  26. Siebenbuerger, L.; Hernandez-Olmos, V.; Abdelsamie, A.S.; Frotscher, M.; Van Koppen, C.J.; Marchais-Oberwinkler, S.; Scheuer, C.; Laschke, M.W.; Menger, M.D.; Boerger, C.; et al. Highly Potent 17β-HSD2 Inhibitors with a Promising Pharmacokinetic Profile for Targeted Osteoporosis Therapy. J. Med. Chem. 2018, 61, 10724–10738. [Google Scholar] [CrossRef]
  27. Cherigo, L.; Lopez, D.; Martinez-Luis, S. Marine Natural Products as Breast Cancer Resistance Protein Inhibitors. Mar. Drugs 2015, 13, 2010–2029. [Google Scholar] [CrossRef]
  28. Netz, N.; Opatz, T. Marine Indole Alkaloids. Mar. Drugs 2015, 13, 4814–4914. [Google Scholar] [CrossRef]
  29. Li, T.; Xu, H. Recent Progress of Bioactivities, Mechanisms of Action, Total Synthesis, Structural Modifications and Structure-Activity Relationships of IndoleDerivatives: A Review. Mini Rev. Med. Chem. 2022, 22, 2702–2725. [Google Scholar] [CrossRef]
  30. Kaushik, N.; Kaushik, N.; Attri, P.; Kumar, N.; Kim, C.; Verma, A.; Choi, E. Biomedical Importance of Indoles. Molecules 2013, 18, 6620–6662. [Google Scholar] [CrossRef]
  31. Erdoğan, I.; Şener, B.; Higa, T. Tryptophol, a plant auxin isolated from the marine sponge Ircinia spinulosa Biochem. Syst. Ecol. 2000, 28, 793–794. [Google Scholar] [CrossRef]
  32. Sugiyama, Y.; Ito, Y.; Suzuki, M.; Hirota, A. Indole Derivatives from a Marine Sponge-Derived Yeast as DPPH Radical Scavengers. J. Nat. Prod. 2009, 72, 2069–2071. [Google Scholar] [CrossRef]
  33. Bao, B.; Zhang, P.; Lee, Y.; Hong, J.; Lee, C.-O.; Jung, J.H. Monoindole Alkaloids from a Marine Sponge Spongosorites Sp. Mar. Drugs 2007, 5, 31–35. [Google Scholar] [CrossRef]
  34. He, W.-F.; Xue, D.-Q.; Yao, L.-G.; Li, J.-Y.; Li, J.; Guo, Y.-W. Hainanerectamines A–C, Alkaloids from the Hainan Sponge Hyrtios erecta. Mar. Drugs 2014, 12, 3982–3993. [Google Scholar] [CrossRef]
  35. Campos, P.-E.; Pichon, E.; Moriou, C.; Clerc, P.; Trépos, R.; Frederich, M.; De Voogd, N.; Hellio, C.; Gauvin-Bialecki, A.; Al-Mourabit, A. New Antimalarial and Antimicrobial Tryptamine Derivatives from the Marine Sponge Fascaplysinopsis reticulata. Mar. Drugs 2019, 17, 167. [Google Scholar] [CrossRef]
  36. Almeida, M.C.; Resende, D.I.S.P.; Da Costa, P.M.; Pinto, M.M.M.; Sousa, E. Tryptophan Derived Natural Marine Alkaloids and Synthetic Derivatives as Promising Antimicrobial Agents. Eur. J. Med. Chem. 2021, 209, 112945–112978. [Google Scholar] [CrossRef]
  37. Li, J.L.; Xiao, B.; Park, M.; Yoo, E.S.; Shin, S.; Hong, J.; Chung, H.Y.; Kim, H.S.; Jung, J.H. PPAR-γ Agonistic Metabolites from the Ascidian Herdmania momus. J. Nat. Prod. 2012, 75, 2082–2087. [Google Scholar] [CrossRef]
  38. Zin, W.W.M.; Buttachon, S.; Dethoup, T.; Pereira, J.A.; Gales, L.; Inácio, Â.; Costa, P.M.; Lee, M.; Sekeroglu, N.; Silva, A.M.; et al. Antibacterial and Antibiofilm Activities of the Metabolites Isolated from the Culture of the Mangrove-Derived Endophytic Fungus Eurotium chevalieri KUFA 0006. Phytochemistry 2017, 141, 86–97. [Google Scholar] [CrossRef]
  39. Shady, N.H.; Fouad, M.A.; Ahmed, S.; Pimentel-Elardo, S.M.; Nodwell, J.R.; Kamel, M.S.; Abdelmohsen, U.R. A New Antitrypanosomal Alkaloid from the Red Sea Marine Sponge Hyrtios Sp. J. Antibiot. 2018, 71, 1036–1039. [Google Scholar] [CrossRef]
  40. Socha, A.M.; Long, R.A.; Rowley, D.C. Bacillamides from a Hypersaline Microbial Mat Bacterium. J. Nat. Prod. 2007, 70, 1793–1795. [Google Scholar] [CrossRef]
  41. Che, Q.; Qiao, L.; Han, X.; Liu, Y.; Wang, W.; Gu, Q.; Zhu, T.; Li, D. Anthranosides A–C, Anthranilate Derivatives from a Sponge-Derived Streptomyces Sp. CMN-62. Org. Lett. 2018, 20, 5466–5469. [Google Scholar] [CrossRef]
  42. Zhong, W.-M.; Wang, J.-F.; Shi, X.-F.; Wei, X.-Y.; Chen, Y.-C.; Zeng, Q.; Xiang, Y.; Chen, X.-Y.; Tian, X.-P.; Xiao, Z.-H.; et al. Eurotiumins A–E, Five New Alkaloids from the Marine-Derived Fungus Eurotium Sp. SCSIO F452. Mar. Drugs 2018, 16, 136. [Google Scholar] [CrossRef]
  43. Youssef, F.S.; Simal-Gandara, J. Comprehensive Overview on the Chemistry and Biological Activities of Selected Alkaloid Producing Marine-Derived Fungi as a Valuable Reservoir of Drug Entities. Biomedicines 2021, 9, 485. [Google Scholar] [CrossRef]
  44. Meng, Z.-H.; Sun, T.-T.; Zhao, G.-Z.; Yue, Y.-F.; Chang, Q.-H.; Zhu, H.-J.; Cao, F. Marine-Derived Fungi as a Source of Bioactive Indole Alkaloids with Diversified Structures. Mar. Life Sci. Technol. 2021, 3, 44–61. [Google Scholar] [CrossRef]
  45. Izumikawa, M.; Hashimoto, J.; Takagi, M.; Shin-ya, K. Isolation of Two New Terpeptin Analogs—JBIR-81 and JBIR-82—From a Seaweed-Derived Fungus, Aspergillus Sp. SpD081030G1f1. J. Antibiot. 2010, 63, 389–391. [Google Scholar] [CrossRef] [PubMed]
  46. Li, J.J. Bartoli Indole Synthesis. In Name Reactions: A Collection of Detailed Mechanisms and Synthetic Applications, 5th ed.; Li, J.J., Ed.; Springer International Publishing: Cham, Switzerland, 2014; pp. 24–25. ISBN 978-3-319-03979-4. [Google Scholar]
  47. Karimi, S.; Ma, S.; Liu, Y.; Ramig, K.; Greer, E.M.; Kwon, K.; Berkowitz, W.F.; Subramaniam, G. Substituted Pyrrole Synthesis from Nitrodienes. Tetrahedron Lett. 2017, 58, 2223–2227. [Google Scholar] [CrossRef]
  48. Kadiyala, V.; Bharath Kumar, P.; Balasubramanian, S.; Karunakar, G.V. Gold-Catalyzed Synthesis of 6-Hydroxyindoles from Alkynylcyclohexadienones and Substituted Amines. J. Org. Chem. 2019, 84, 12228–12236. [Google Scholar] [CrossRef] [PubMed]
  49. Dorel, R.; Echavarren, A.M. Gold(I)-Catalyzed Activation of Alkynes for the Construction of Molecular Complexity. Chem. Rev. 2015, 115, 9028–9072. [Google Scholar] [CrossRef]
  50. Capon, R.J.; Peng, C.; Dooms, C. Trachycladindoles A–G: Cytotoxic Heterocycles from an Australian Marine Sponge, Trachycladus laevispirulifer. Org. Biomol. Chem. 2008, 6, 2765–2772. [Google Scholar] [CrossRef] [PubMed]
  51. Segraves, N.L.; Crews, P. Investigation of Brominated Tryptophan Alkaloids from Two Thorectidae Sponges: Thorectandra and Smenospongia. J. Nat. Prod. 2005, 68, 1484–1488. [Google Scholar] [CrossRef] [PubMed]
  52. Hu, J.-F.; Schetz, J.A.; Kelly, M.; Peng, J.-N.; Ang, K.K.H.; Flotow, H.; Leong, C.Y.; Ng, S.B.; Buss, A.D.; Wilkins, S.P.; et al. New Antiinfective and Human 5-HT2 Receptor Binding Natural and Semisynthetic Compounds from the Jamaican Sponge Smenospongia aurea. J. Nat. Prod. 2002, 65, 476–480. [Google Scholar] [CrossRef] [PubMed]
  53. Hentz, A. Vers la Synthèse Totale du Trachycladindole E, Développement de Nouvelles Réactivités des Ynamides. Ph.D. Thesis, Université Paris Sud-Paris XI, Paris, France, 2014. [Google Scholar]
  54. Stanovnik, B.; Svete, J. The Synthesis of Aplysinopsins, Meridianines, and Related Compounds. Mini-Rev. Org. Chem. 2005, 2, 211–224. [Google Scholar] [CrossRef]
  55. Franco, L.H.; Joffé, E.B.D.K.; Puricelli, L.; Tatian, M.; Seldes, A.M.; Palermo, J.A. Indole Alkaloids from the Tunicate Aplidium meridianum. J. Nat. Prod. 1998, 61, 1130–1132. [Google Scholar] [CrossRef] [PubMed]
  56. Xiao, L. A Review: Meridianins and Meridianins Derivatives. Molecules 2022, 27, 8714. [Google Scholar] [CrossRef] [PubMed]
  57. Han, S.; Zhuang, C.; Zhou, W.; Chen, F. Structural-Based Optimizations of the Marine-Originated Meridianin C as Glucose Uptake Agents by Inhibiting GSK-3β. Mar. Drugs 2021, 19, 149. [Google Scholar] [CrossRef]
  58. Kruppa, M.; Müller, T.J.J. A Survey on the Synthesis of Variolins, Meridianins, and Meriolins—Naturally Occurring Marine (Aza)Indole Alkaloids and Their Semisynthetic Derivatives. Molecules 2023, 28, 947. [Google Scholar] [CrossRef] [PubMed]
  59. Fresneda, P.M.; Molina, P.; Bleda, J.A. Synthesis of the Indole Alkaloids Meridianins from the Tunicate Aplidium meridianum. Tetrahedron 2001, 57, 2355–2363. [Google Scholar] [CrossRef]
  60. Karpov, A.S.; Merkul, E.; Rominger, F.; Müller, T.J.J. Concise Syntheses of Meridianins by Carbonylative Alkynylation and a Four-Component Pyrimidine Synthesis. Angew. Chem. Int. Ed. 2005, 44, 6951–6956. [Google Scholar] [CrossRef]
  61. Kruppa, M.; Sommer, G.A.; Müller, T.J.J. Concise Syntheses of Marine (Bis)Indole Alkaloids Meridianin C, D, F, and G and Scalaridine A via One-Pot Masuda Borylation-Suzuki Coupling Sequence. Molecules 2022, 27, 2233. [Google Scholar] [CrossRef]
  62. Tibiletti, F.; Simonetti, M.; Nicholas, K.M.; Palmisano, G.; Parravicini, M.; Imbesi, F.; Tollari, S.; Penoni, A. One-Pot Synthesis of Meridianins and Meridianin Analogues via Indolization of Nitrosoarenes. Tetrahedron 2010, 66, 1280–1288. [Google Scholar] [CrossRef]
  63. Liu, H.-B.; Lauro, G.; O’Connor, R.D.; Lohith, K.; Kelly, M.; Colin, P.; Bifulco, G.; Bewley, C.A. Tulongicin, an Antibacterial Tri-Indole Alkaloid from a Deep-Water Topsentia Sp. Sponge. J. Nat. Prod. 2017, 80, 2556–2560. [Google Scholar] [CrossRef] [PubMed]
  64. Sato, H.; Tsuda, M.; Watanabe, K.; Kobayashi, J. Rhopaladins A ∼ D, New Indole Alkaloids from Marine Tunicate Rhopalaea Sp. Tetrahedron 1998, 54, 8687–8690. [Google Scholar] [CrossRef]
  65. Zoraghi, R.; Worrall, L.; See, R.H.; Strangman, W.; Popplewell, W.L.; Gong, H.; Samaai, T.; Swayze, R.D.; Kaur, S.; Vuckovic, M.; et al. Methicillin-Resistant Staphylococcus aureus (MRSA) Pyruvate Kinase as a Target for Bis-Indole Alkaloids with Antibacterial Activities. J. Biol. Chem. 2011, 286, 44716–44725. [Google Scholar] [CrossRef] [PubMed]
  66. Tapiolas, D.M.; Bowden, B.F.; Abou-Mansour, E.; Willis, R.H.; Doyle, J.R.; Muirhead, A.N.; Liptrot, C.; Llewellyn, L.E.; Wolff, C.W.W.; Wright, A.D.; et al. Eusynstyelamides A, B, and C, nNOS Inhibitors, from the Ascidian Eusynstyela latericius. J. Nat. Prod. 2009, 72, 1115–1120. [Google Scholar] [CrossRef] [PubMed]
  67. Tadesse, M.; Tabudravu, J.N.; Jaspars, M.; Strøm, M.B.; Hansen, E.; Andersen, J.H.; Kristiansen, P.E.; Haug, T. The Antibacterial Ent-Eusynstyelamide B and Eusynstyelamides D, E, and F from the Arctic Bryozoan Tegella cf. spitzbergensis. J. Nat. Prod. 2011, 74, 837–841. [Google Scholar] [CrossRef] [PubMed]
  68. Gunasekera, S.P.; McCarthy, P.J.; Kelly-Borges, M. Hamacanthins A and B, New Antifungal Bis Indole Alkaloids from the Deep-Water Marine Sponge, Hamacantha Sp. J. Nat. Prod. 1994, 57, 1437–1441. [Google Scholar] [CrossRef]
  69. Ma, Y.-M.; Liang, X.-A.; Kong, Y.; Jia, B. Structural Diversity and Biological Activities of Indole Diketopiperazine Alkaloids from Fungi. J. Agric. Food Chem. 2016, 64, 6659–6671. [Google Scholar] [CrossRef]
  70. Wang, X.; Li, Y.; Zhang, X.; Lai, D.; Zhou, L. Structural Diversity and Biological Activities of the Cyclodipeptides from Fungi. Molecules 2017, 22, 2026. [Google Scholar] [CrossRef]
  71. Borthwick, A.D. 2,5-Diketopiperazines: Synthesis, Reactions, Medicinal Chemistry, and Bioactive Natural Products. Chem. Rev. 2012, 112, 3641–3716. [Google Scholar] [CrossRef] [PubMed]
  72. Li, G.-Y.; Yang, T.; Luo, Y.-G.; Chen, X.-Z.; Fang, D.-M.; Zhang, G.-L. Brevianamide J, A New Indole Alkaloid Dimer from Fungus Aspergillus versicolor. Org. Lett. 2009, 11, 3714–3717. [Google Scholar] [CrossRef] [PubMed]
  73. Huang, P.; Xie, F.; Ren, B.; Wang, Q.; Wang, J.; Wang, Q.; Abdel-Mageed, W.M.; Liu, M.; Han, J.; Oyeleye, A.; et al. Anti-MRSA and Anti-TB Metabolites from Marine-Derived Verrucosispora Sp. MS100047. Appl. Microbiol. Biotechnol. 2016, 100, 7437–7447. [Google Scholar] [CrossRef]
  74. Song, F.; Liu, X.; Guo, H.; Ren, B.; Chen, C.; Piggott, A.M.; Yu, K.; Gao, H.; Wang, Q.; Liu, M.; et al. Brevianamides with Antitubercular Potential from a Marine-Derived Isolate of Aspergillus versicolor. Org. Lett. 2012, 14, 4770–4773. [Google Scholar] [CrossRef] [PubMed]
  75. Asiri, I.A.M.; Badr, J.M.; Youssef, D.T.A. Penicillivinacine, Antimigratory Diketopiperazine Alkaloid from the Marine-Derived Fungus Penicillium vinaceum. Phytochem. Lett. 2015, 13, 53–58. [Google Scholar] [CrossRef]
  76. El-Gendy, B.E.-D.M.; Rateb, M.E. Antibacterial Activity of Diketopiperazines Isolated from a Marine Fungus Using T-Butoxycarbonyl Group as a Simple Tool for Purification. Bioorg. Med. Chem. Lett. 2015, 25, 3125–3128. [Google Scholar] [CrossRef] [PubMed]
  77. Zhang, M.; Wang, W.-L.; Fang, Y.-C.; Zhu, T.-J.; Gu, Q.-Q.; Zhu, W.-M. Cytotoxic Alkaloids and Antibiotic Nordammarane Triterpenoids from the Marine-Derived Fungus Aspergillus sydowi. J. Nat. Prod. 2008, 71, 985–989. [Google Scholar] [CrossRef] [PubMed]
  78. Di, X.; Rouger, C.; Hardardottir, I.; Freysdottir, J.; Molinski, T.F.; Tasdemir, D.; Omarsdottir, S. 6-Bromoindole Derivatives from the Icelandic Marine Sponge Geodia Barretti: Isolation and Anti-Inflammatory Activity. Mar. Drugs 2018, 16, 437. [Google Scholar] [CrossRef] [PubMed]
  79. Olsen, E.K.; Hansen, E.; Moodie, L.W.K.; Isaksson, J.; Sepčić, K.; Cergolj, M.; Svenson, J.; Andersen, J.H. Marine AChE Inhibitors Isolated from Geodia Barretti: Natural Compounds and Their Synthetic Analogs. Org. Biomol. Chem. 2016, 14, 1629–1640. [Google Scholar] [CrossRef] [PubMed]
  80. Hedner, E.; Sjögren, M.; Frändberg, P.-A.; Johansson, T.; Göransson, U.; Dahlström, M.; Jonsson, P.; Nyberg, F.; Bohlin, L. Brominated Cyclodipeptides from the Marine Sponge Geodia Barretti as Selective 5-HT Ligands. J. Nat. Prod. 2006, 69, 1421–1424. [Google Scholar] [CrossRef]
  81. Chen, X.; Si, L.; Liu, D.; Proksch, P.; Zhang, L.; Zhou, D.; Lin, W. Neoechinulin B and Its Analogues as Potential Entry Inhibitors of Influenza Viruses, Targeting Viral Hemagglutinin. Eur. J. Med. Chem. 2015, 93, 182–195. [Google Scholar] [CrossRef]
  82. Kamauchi, H.; Kinoshita, K.; Sugita, T.; Koyama, K. Conditional Changes Enhanced Production of Bioactive Metabolites of Marine Derived Fungus Eurotium rubrum. Bioorg. Med. Chem. Lett. 2016, 26, 4911–4914. [Google Scholar] [CrossRef]
  83. Du, F.-Y.; Li, X.; Li, X.-M.; Zhu, L.-W.; Wang, B.-G. Indolediketopiperazine Alkaloids from Eurotium cristatum EN-220, an Endophytic Fungus Isolated from the Marine Alga Sargassum thunbergii. Mar. Drugs 2017, 15, 24. [Google Scholar] [CrossRef]
  84. Yan, H.; Li, X.; Li, C.; Wang, B. Alkaloid and Anthraquinone Derivatives Produced by the Marine-Derived Endophytic Fungus Eurotium rubrum. Helv. Chim. Acta 2012, 95, 163–168. [Google Scholar] [CrossRef]
  85. Du, F.-Y.; Li, X.-M.; Li, C.-S.; Shang, Z.; Wang, B.-G. Cristatumins A–D, New Indole Alkaloids from the Marine-Derived Endophytic Fungus Eurotium cristatum EN-220. Bioorg. Med. Chem. Lett. 2012, 22, 4650–4653. [Google Scholar] [CrossRef]
  86. Liu, Z.; Chen, Y.; Li, S.; Hu, C.; Liu, H.; Zhang, W. Indole Diketopiperazine Alkaloids from the Deep-Sea-Derived Fungus Aspergillus Sp. FS445. Nat. Prod. Res. 2022, 36, 5213–5221. [Google Scholar] [CrossRef] [PubMed]
  87. Li, Y.; Li, X.; Kim, S.-K.; Kang, J.S.; Choi, H.D.; Rho, J.R.; Son, B.W. Golmaenone, a New Diketopiperazine Alkaloid from the Marine-Derived Fungus Aspergillus Sp. Chem. Pharm. Bull. 2004, 52, 375–376. [Google Scholar] [CrossRef] [PubMed]
  88. Kim, M.C.; Cullum, R.; Machado, H.; Smith, A.J.; Yang, I.; Rodvold, J.J.; Fenical, W. Photopiperazines A–D, Photosensitive Interconverting Diketopiperazines with Significant and Selective Activity against U87 Glioblastoma Cells, from a Rare, Marine-Derived Actinomycete of the Family Streptomycetaceae. J. Nat. Prod. 2019, 82, 2262–2267. [Google Scholar] [CrossRef] [PubMed]
  89. Tang, X.-D.; Li, S.; Guo, R.; Nie, J.; Ma, J.-A. Chiral Phosphoric Acid Catalyzed Enantioselective Decarboxylative Alkylation of β-Keto Acids with 3-Hydroxy-3-Indolyloxindoles. Org. Lett. 2015, 17, 1389–1392. [Google Scholar] [CrossRef]
  90. Cai, S.; Kong, X.; Wang, W.; Zhou, H.; Zhu, T.; Li, D.; Gu, Q. Aspergilazine A, a Diketopiperazine Dimer with a Rare N-1 to C-6 Linkage, from a Marine-Derived Fungus Aspergillus taichungensis. Tetrahedron Lett. 2012, 53, 2615–2617. [Google Scholar] [CrossRef]
  91. Boyd, E.M.; Sperry, J. Total Synthesis of (−)-Aspergilazine A. Org. Lett. 2014, 16, 5056–5059. [Google Scholar] [CrossRef] [PubMed]
  92. Li, P.; Zhang, M.; Li, H.; Wang, R.; Hou, H.; Li, X.; Liu, K.; Chen, H. New Prenylated Indole Homodimeric and Pteridine Alkaloids from the Marine-Derived Fungus Aspergillus austroafricanus Y32-2. Mar. Drugs 2021, 19, 98. [Google Scholar] [CrossRef] [PubMed]
  93. Majumdar, K.C.; Ray, K.; Ganai, S. Intramolecular Aza-Wittig Reaction: A New Efficient Tool for the Construction of Piperazine 2,5-Dione Derivatives. Synlett 2010, 2010, 2122–2124. [Google Scholar] [CrossRef]
  94. Ashnagar, A.; Bailey, P.D.; Cochrane, P.J.; Mills, T.J.; Price, R.A. Unusual Rearrangements and Cyclizations Involving Polycyclic Indolic Systems. Arkivoc 2007, 2007, 161–171. [Google Scholar] [CrossRef]
  95. Torres-García, C.; Díaz, M.; Blasi, D.; Farràs, I.; Fernández, I.; Ariza, X.; Farràs, J.; Lloyd-Williams, P.; Royo, M.; Nicolás, E. Side Chain Anchoring of Tryptophan to Solid Supports Using a Dihydropyranyl Handle: Synthesis of Brevianamide F. Int. J. Pept. Res. Ther. 2012, 18, 7–19. [Google Scholar] [CrossRef]
  96. Kuramochi, K.; Aoki, T.; Nakazaki, A.; Kamisuki, S.; Takeno, M.; Ohnishi, K.; Kimoto, K.; Watanabe, N.; Kamakura, T.; Arai, T.; et al. Synthesis of Neoechinulin A and Derivatives. Synthesis 2008, 23, 3810–3818. [Google Scholar]
  97. Li, H.; Sun, W.; Deng, M.; Zhou, Q.; Wang, J.; Liu, J.; Chen, C.; Qi, C.; Luo, Z.; Xue, Y.; et al. Asperversiamides, Linearly Fused Prenylated Indole Alkaloids from the Marine-Derived Fungus Aspergillus versicolor. J. Org. Chem. 2018, 83, 8483–8492. [Google Scholar] [CrossRef] [PubMed]
  98. Zhang, P.; Li, X.-M.; Wang, J.-N.; Li, X.; Wang, B.-G. Prenylated Indole Alkaloids from the Marine-Derived Fungus Paecilomyces variotii. Chin. Chem. Lett. 2015, 26, 313–316. [Google Scholar] [CrossRef]
  99. Williams, R.M.; Cox, R.J. Paraherquamides, Brevianamides, and Asperparalines:  Laboratory Synthesis and Biosynthesis. An Interim Report. Acc. Chem. Res. 2003, 36, 127–139. [Google Scholar] [CrossRef]
  100. Ding, Y.; Wet, J.R.D.; Cavalcoli, J.; Li, S.; Greshock, T.J.; Miller, K.A.; Finefield, J.M.; Sunderhaus, J.D.; McAfoos, T.J.; Tsukamoto, S.; et al. Genome-Based Characterization of Two Prenylation Steps in the Assembly of the Stephacidin and Notoamide Anticancer Agents in a Marine-Derived Aspergillus Sp. J. Am. Chem. Soc. 2010, 132, 12733–12740. [Google Scholar] [CrossRef]
  101. Klas, K.R.; Kato, H.; Frisvad, J.C.; Yu, F.; Newmister, S.A.; Fraley, A.E.; Sherman, D.H.; Tsukamoto, S.; Williams, R.M. Structural and Stereochemical Diversity in Prenylated Indole Alkaloids Containing the Bicyclo[2.2.2]diazaoctane Ring System from Marine and Terrestrial Fungi. Nat. Prod. Rep. 2018, 35, 532–558. [Google Scholar] [CrossRef]
  102. Zhang, X.-Y.; Xu, X.-Y.; Peng, J.; Ma, C.-F.; Nong, X.-H.; Bao, J.; Zhang, G.-Z.; Qi, S.-H. Antifouling Potentials of Eight Deep-Sea-Derived Fungi from the South China Sea. J. Ind. Microbiol. Biotechnol. 2014, 41, 741–748. [Google Scholar] [CrossRef]
  103. Afiyatullov, S.S.; Zhuravleva, O.I.; Antonov, A.S.; Berdyshev, D.V.; Pivkin, M.V.; Denisenko, V.A.; Popov, R.S.; Gerasimenko, A.V.; von Amsberg, G.; Dyshlovoy, S.A.; et al. Prenylated Indole Alkaloids from Co-Culture of Marine-Derived Fungi Aspergillus sulphureus and Isaria felina. J. Antibiot. 2018, 71, 846–853. [Google Scholar] [CrossRef] [PubMed]
  104. Cai, S.; Luan, Y.; Kong, X.; Zhu, T.; Gu, Q.; Li, D. Isolation and Photoinduced Conversion of 6-Epi-Stephacidins from Aspergillus taichungensis. Org. Lett. 2013, 15, 2168–2171. [Google Scholar] [CrossRef] [PubMed]
  105. Yang, J.; Gong, L.; Guo, M.; Jiang, Y.; Ding, Y.; Wang, Z.; Xin, X.; An, F. Bioactive Indole Diketopiperazine Alkaloids from the Marine Endophytic Fungus Aspergillus Sp. YJ191021. Mar. Drugs 2021, 19, 157. [Google Scholar] [CrossRef] [PubMed]
  106. Peng, J.; Gao, H.; Li, J.; Ai, J.; Geng, M.; Zhang, G.; Zhu, T.; Gu, Q.; Li, D. Prenylated Indole Diketopiperazines from the Marine-Derived Fungus Aspergillus versicolor. J. Org. Chem. 2014, 79, 7895–7904. [Google Scholar] [CrossRef] [PubMed]
  107. Godfrey, R.C.; Jones, H.E.; Green, N.J.; Lawrence, A.L. Unified Total Synthesis of the Brevianamide Alkaloids Enabled by Chemical Investigations into Their Biosynthesis. Chem. Sci. 2022, 13, 1313–1322. [Google Scholar] [CrossRef]
  108. Catalano, A.; Iacopetta, D.; Ceramella, J.; Saturnino, C.; Sinicropi, M.S. A Comprehensive Review on Pyranoindole-Containing Agents. Curr. Med. Chem. 2022, 29, 3667–3683. [Google Scholar] [CrossRef]
  109. Wang, C.; Wang, T.; Huang, L.; Hou, Y.; Lu, W.; He, H. Facile Synthetic Approach for 5-Aryl-9-Hydroxypyrano [3,2-f] Indole-2(8H)-One. Arab. J. Chem. 2016, 9, 882–890. [Google Scholar] [CrossRef]
  110. Grubbs, A.W.; Artman, G.D.; Williams, R.M. Concise Syntheses of the 1,7-Dihydropyrano[2,3-g]Indole Ring System of the Stephacidins, Aspergamides and Norgeamides. Tetrahedron Lett. 2005, 46, 9013–9016. [Google Scholar] [CrossRef]
  111. Zhong, W.; Wang, J.; Wei, X.; Fu, T.; Chen, Y.; Zeng, Q.; Huang, Z.; Huang, X.; Zhang, W.; Zhang, S.; et al. Three Pairs of New Spirocyclic Alkaloid Enantiomers From the Marine-Derived Fungus Eurotium Sp. SCSIO F452. Front. Chem. 2019, 7, 350. [Google Scholar] [CrossRef]
  112. Wang, F.; Fang, Y.; Zhu, T.; Zhang, M.; Lin, A.; Gu, Q.; Zhu, W. Seven New Prenylated Indole Diketopiperazine Alkaloids from Holothurian-Derived Fungus Aspergillus fumigatus. Tetrahedron 2008, 64, 7986–7991. [Google Scholar] [CrossRef]
  113. Gao, H.; Liu, W.; Zhu, T.; Mo, X.; Mándi, A.; Kurtán, T.; Li, J.; Ai, J.; Gu, Q.; Li, D. Diketopiperazine Alkaloids from a Mangrove Rhizosphere Soil Derived Fungus Aspergillus effuses H1-1. Org. Biomol. Chem. 2012, 10, 9501–9506. [Google Scholar] [CrossRef]
  114. Zhong, W.; Wang, J.; Wei, X.; Chen, Y.; Fu, T.; Xiang, Y.; Huang, X.; Tian, X.; Xiao, Z.; Zhang, W.; et al. Variecolortins A–C, Three Pairs of Spirocyclic Diketopiperazine Enantiomers from the Marine-Derived Fungus Eurotium Sp. SCSIO F452. Org. Lett. 2018, 20, 4593–4596. [Google Scholar] [CrossRef] [PubMed]
  115. Chen, G.-D.; Bao, Y.-R.; Huang, Y.-F.; Hu, D.; Li, X.-X.; Guo, L.-D.; Li, J.; Yao, X.-S.; Gao, H. Three Pairs of Variecolortide Enantiomers from Eurotium Sp. with Caspase-3 Inhibitory Activity. Fitoterapia 2014, 92, 252–259. [Google Scholar] [CrossRef] [PubMed]
  116. An, C.-Y.; Li, X.-M.; Li, C.-S.; Xu, G.-M.; Wang, B.-G. Prenylated Indolediketopiperazine Peroxides and Related Homologues from the Marine Sediment-Derived Fungus Penicillium Brefeldianum SD-273. Mar. Drugs 2014, 12, 746–756. [Google Scholar] [CrossRef]
  117. Bunders, C.; Cavanagh, J.; Melander, C. Flustramine Inspired Synthesis and Biological Evaluation of Pyrroloindoline Triazole Amides as Novel Inhibitors of Bacterial Biofilms. Org. Biomol. Chem. 2011, 9, 5476–5481. [Google Scholar] [CrossRef]
  118. Wang, Y.; Li, Z.-L.; Bai, J.; Zhang, L.-M.; Wu, X.; Zhang, L.; Pei, Y.-H.; Jing, Y.-K.; Hua, H.-M. 2,5-Diketopiperazines from the Marine-Derived Fungus Aspergillus fumigatus YK-7. Chem. Biodivers. 2012, 9, 385–393. [Google Scholar] [CrossRef] [PubMed]
  119. Du, L.; Yang, X.; Zhu, T.; Wang, F.; Xiao, X.; Park, H.; Gu, Q. Diketopiperazine Alkaloids from a Deep Ocean Sediment Derived Fungus Penicillium Sp. Chem. Pharm. Bull. 2009, 57, 873–876. [Google Scholar] [CrossRef] [PubMed]
  120. Khalil, Z.G.; Huang, X.; Raju, R.; Piggott, A.M.; Capon, R.J. Shornephine A: Structure, Chemical Stability, and P-Glycoprotein Inhibitory Properties of a Rare Diketomorpholine from an Australian Marine-Derived Aspergillus Sp. J. Org. Chem. 2014, 79, 8700–8705. [Google Scholar] [CrossRef]
  121. Cai, S.; Sun, S.; Peng, J.; Kong, X.; Zhou, H.; Zhu, T.; Gu, Q.; Li, D. Okaramines S–U, Three New Indole Diketopiperazine Alkaloids from Aspergillus taichungensis ZHN-7-07. Tetrahedron 2015, 71, 3715–3719. [Google Scholar] [CrossRef]
  122. Ding, L.; Maier, A.; Fiebig, H.-H.; Lin, W.-H.; Hertweck, C. A Family of Multicyclic Indolosesquiterpenes from a Bacterial Endophyte. Org. Biomol. Chem. 2011, 9, 4029–4031. [Google Scholar] [CrossRef]
  123. Che, Q.; Zhu, T.; Keyzers, R.A.; Liu, X.; Li, J.; Gu, Q.; Li, D. Polycyclic Hybrid Isoprenoids from a Reed Rhizosphere Soil Derived Streptomyces Sp. CHQ-64. J. Nat. Prod. 2013, 76, 759–763. [Google Scholar] [CrossRef] [PubMed]
  124. Che, Q.; Zhu, T.; Qi, X.; Mándi, A.; Kurtán, T.; Mo, X.; Li, J.; Gu, Q.; Li, D. Hybrid Isoprenoids from a Reeds Rhizosphere Soil Derived Actinomycete Streptomyces Sp. CHQ-64. Org. Lett. 2012, 14, 3438–3441. [Google Scholar] [CrossRef] [PubMed]
  125. Raju, R.; Piggott, A.M.; Huang, X.-C.; Capon, R.J. Nocardioazines: A Novel Bridged Diketopiperazine Scaffold from a Marine-Derived Bacterium Inhibits P-Glycoprotein. Org. Lett. 2011, 13, 2770–2773. [Google Scholar] [CrossRef] [PubMed]
  126. Jia, B.; Ma, Y.; Liu, B.; Chen, P.; Hu, Y.; Zhang, R. Synthesis, Antimicrobial Activity, Structure-Activity Relationship, and Molecular Docking Studies of Indole Diketopiperazine Alkaloids. Front. Chem. 2019, 7, 837. [Google Scholar] [CrossRef] [PubMed]
  127. Adla, S.K.; Sasse, F.; Kelter, G.; Fiebig, H.-H.; Lindel, T. Doubly Prenylated Tryptamines: Cytotoxicity, Antimicrobial Activity and Cyclisation to the Marine Natural Product Flustramine A. Org. Biomol. Chem. 2013, 11, 6119–6130. [Google Scholar] [CrossRef] [PubMed]
  128. Ruiz-Sanchis, P.; Savina, S.A.; Albericio, F.; Álvarez, M. Structure, Bioactivity and Synthesis of Natural Products with Hexahydropyrrolo[2,3-b]Indole. Chem. Eur. J. 2011, 17, 1388–1408. [Google Scholar] [CrossRef] [PubMed]
  129. Huang, H.; Yao, Y.; He, Z.; Yang, T.; Ma, J.; Tian, X.; Li, Y.; Huang, C.; Chen, X.; Li, W.; et al. Antimalarial β-Carboline and Indolactam Alkaloids from Marinactinospora Thermotolerans, a Deep Sea Isolate. J. Nat. Prod. 2011, 74, 2122–2127. [Google Scholar] [CrossRef] [PubMed]
  130. Guo, Y.-W.; Liu, X.-J.; Yuan, J.; Li, H.-J.; Mahmud, T.; Hong, M.-J.; Yu, J.-C.; Lan, W.-J. L-Tryptophan Induces a Marine-Derived Fusarium Sp. to Produce Indole Alkaloids with Activity against the Zika Virus. J. Nat. Prod. 2020, 83, 3372–3380. [Google Scholar] [CrossRef]
  131. Kong, F.-D.; Fan, P.; Zhou, L.-M.; Ma, Q.-Y.; Xie, Q.-Y.; Zheng, H.-Z.; Zheng, Z.-H.; Zhang, R.-S.; Yuan, J.-Z.; Dai, H.-F.; et al. Penerpenes A–D, Four Indole Terpenoids with Potent Protein Tyrosine Phosphatase Inhibitory Activity from the Marine-Derived Fungus Penicillium Sp. KFD28. Org. Lett. 2019, 21, 4864–4867. [Google Scholar] [CrossRef]
  132. Zhou, L.-M.; Kong, F.-D.; Fan, P.; Ma, Q.-Y.; Xie, Q.-Y.; Li, J.-H.; Zheng, H.-Z.; Zheng, Z.-H.; Yuan, J.-Z.; Dai, H.-F.; et al. Indole-Diterpenoids with Protein Tyrosine Phosphatase Inhibitory Activities from the Marine-Derived Fungus Penicillium Sp. KFD28. J. Nat. Prod. 2019, 82, 2638–2644. [Google Scholar] [CrossRef]
  133. Mugishima, T.; Tsuda, M.; Kasai, Y.; Ishiyama, H.; Fukushi, E.; Kawabata, J.; Watanabe, M.; Akao, K.; Kobayashi, J. Absolute Stereochemistry of Citrinadins A and B from Marine-Derived Fungus. J. Org. Chem. 2005, 70, 9430–9435. [Google Scholar] [CrossRef] [PubMed]
  134. Du, L.; Li, D.; Zhu, T.; Cai, S.; Wang, F.; Xiao, X.; Gu, Q. New Alkaloids and Diterpenes from a Deep Ocean Sediment Derived Fungus Penicillium Sp. Tetrahedron 2009, 65, 1033–1039. [Google Scholar] [CrossRef]
  135. Du, L.; Feng, T.; Zhao, B.; Li, D.; Cai, S.; Zhu, T.; Wang, F.; Xiao, X.; Gu, Q. Alkaloids from a Deep Ocean Sediment-Derived Fungus Penicillium Sp. and Their Antitumor Activities. J. Antibiot. 2010, 63, 165–170. [Google Scholar] [CrossRef] [PubMed]
  136. Sallam, A.A.; Houssen, W.E.; Gissendanner, C.R.; Orabi, K.Y.; Foudah, A.I.; Sayed, K.A.E. Bioguided Discovery and Pharmacophore Modeling of the Mycotoxic Indole Diterpene Alkaloids Penitrems as Breast Cancer Proliferation, Migration, and Invasion Inhibitors. Med. Chem. Commun. 2013, 4, 1360–1369. [Google Scholar] [CrossRef] [PubMed]
  137. Zhang, P.; Li, X.-M.; Li, X.; Wang, B.-G. New Indole-Diterpenoids from the Algal-Associated Fungus Aspergillus nidulans. Phytochem. Lett. 2015, 12, 182–185. [Google Scholar] [CrossRef]
  138. Ivanets, E.V.; Yurchenko, A.N.; Smetanina, O.F.; Rasin, A.B.; Zhuravleva, O.I.; Pivkin, M.V.; Popov, R.S.; Von Amsberg, G.; Afiyatullov, S.S.; Dyshlovoy, S.A. Asperindoles A–D and a p-Terphenyl Derivative from the Ascidian-Derived Fungus Aspergillus Sp. KMM 4676. Mar. Drugs 2018, 16, 232. [Google Scholar] [CrossRef] [PubMed]
  139. Zhou, G.; Sun, C.; Hou, X.; Che, Q.; Zhang, G.; Gu, Q.; Liu, C.; Zhu, T.; Li, D. Ascandinines A–D, Indole Diterpenoids, from the Sponge-Derived Fungus Aspergillus candidus HDN15-152. J. Org. Chem. 2021, 86, 2431–2436. [Google Scholar] [CrossRef] [PubMed]
  140. Makarieva, T.N.; Ilyin, S.G.; Stonik, V.A.; Lyssenko, K.A.; Denisenko, V.A. Pibocin, the First Ergoline Marine Alkaloid from the Far-Eastern Ascidian Eudistoma Sp. Tetrahedron Lett. 1999, 40, 1591–1594. [Google Scholar] [CrossRef]
  141. Makarieva, T.N.; Dmitrenok, A.S.; Dmitrenok, P.S.; Grebnev, B.B.; Stonik, V.A. Pibocin B, the First N-O-Methylindole Marine Alkaloid, a Metabolite from the Far-Eastern Ascidian Eudistoma Species. J. Nat. Prod. 2001, 64, 1559–1561. [Google Scholar] [CrossRef]
  142. Kong, F.-D.; Zhang, S.-L.; Zhou, S.-Q.; Ma, Q.-Y.; Xie, Q.-Y.; Chen, J.-P.; Li, J.-H.; Zhou, L.-M.; Yuan, J.-Z.; Hu, Z.; et al. Quinazoline-Containing Indole Alkaloids from the Marine-Derived Fungus Aspergillus Sp. HNMF114. J. Nat. Prod. 2019, 82, 3456–3463. [Google Scholar] [CrossRef]
  143. Li, Y.-X.; Himaya, S.W.A.; Dewapriya, P.; Zhang, C.; Kim, S.-K. Fumigaclavine C from a Marine-Derived Fungus Aspergillus fumigatus Induces Apoptosis in MCF-7 Breast Cancer Cells. Mar. Drugs 2013, 11, 5063–5086. [Google Scholar] [CrossRef] [PubMed]
  144. Limbadri, S.; Luo, X.; Lin, X.; Liao, S.; Wang, J.; Zhou, X.; Yang, B.; Liu, Y. Bioactive Novel Indole Alkaloids and Steroids from Deep Sea-Derived Fungus Aspergillus fumigatus SCSIO 41012. Molecules 2018, 23, 2379. [Google Scholar] [CrossRef] [PubMed]
  145. Fremlin, L.J.; Piggott, A.M.; Lacey, E.; Capon, R.J. Cottoquinazoline A and Cotteslosins A and B, Metabolites from an Australian Marine-Derived Strain of Aspergillus versicolor. J. Nat. Prod. 2009, 72, 666–670. [Google Scholar] [CrossRef] [PubMed]
  146. Zhuang, Y.; Teng, X.; Wang, Y.; Liu, P.; Li, G.; Zhu, W. New Quinazolinone Alkaloids within Rare Amino Acid Residue from Coral-Associated Fungus, Aspergillus versicolor LCJ-5-4. Org. Lett. 2011, 13, 1130–1133. [Google Scholar] [CrossRef] [PubMed]
  147. Huang, L.-H.; Xu, M.-Y.; Li, H.-J.; Li, J.-Q.; Chen, Y.-X.; Ma, W.-Z.; Li, Y.-P.; Xu, J.; Yang, D.-P.; Lan, W.-J. Amino Acid-Directed Strategy for Inducing the Marine-Derived Fungus Scedosporium Apiospermum F41–1 to Maximize Alkaloid Diversity. Org. Lett. 2017, 19, 4888–4891. [Google Scholar] [CrossRef] [PubMed]
  148. Hansen, K.Ø.; Isaksson, J.; Bayer, A.; Johansen, J.A.; Andersen, J.H.; Hansen, E. Securamine Derivatives from the Arctic Bryozoan Securiflustra Securifrons. J. Nat. Prod. 2017, 80, 3276–3283. [Google Scholar] [CrossRef] [PubMed]
  149. Adesanya, S.A.; Chbani, M.; Païs, M.; Debitus, C. Brominated β-Carbolines from the Marine Tunicate Eudistoma Album. J. Nat. Prod. 1992, 55, 525–527. [Google Scholar] [CrossRef] [PubMed]
  150. Sandler, J.S.; Colin, P.L.; Hooper, J.N.A.; Faulkner, D.J. Cytotoxic β-Carbolines and Cyclic Peroxides from the Palauan Sponge Plakortis nigra. J. Nat. Prod. 2002, 65, 1258–1261. [Google Scholar] [CrossRef]
  151. Kleks, G.; Duffy, S.; Lucantoni, L.; Avery, V.M.; Carroll, A.R. Orthoscuticellines A–E, β-Carboline Alkaloids from the Bryozoan Orthoscuticella Ventricosa Collected in Australia. J. Nat. Prod. 2020, 83, 422–428. [Google Scholar] [CrossRef]
  152. Carson, C.C.; Rajfer, J.; Eardley, I.; Carrier, S.; Denne, J.S.; Walker, D.J.; Shen, W.; Cordell, W.H. The Efficacy and Safety of Tadalafil: An Update. BJU Int. 2004, 93, 1276–1281. [Google Scholar] [CrossRef]
  153. Wibowo, D.N.S.A.; Soebadi, D.M.; Soebadi, M.A. Yohimbine as a Treatment for Erectile Dysfunction: A Systematic Review and Meta-Analysis. Turk. J. Urol. 2021, 47, 482–488. [Google Scholar] [CrossRef]
  154. Shamon, S.D.; Perez, M.I. Blood Pressure-lowering Efficacy of Reserpine for Primary Hypertension. Cochrane Database Syst. Rev. 2016, 12, 1–32. [Google Scholar] [CrossRef] [PubMed]
  155. Moyer, J.H.; Kinard, S.A.; Herschberger, R.; Dennis, E.W. Deserpidine (Canescine) for the Treatment of Hypertension. South. Med. J. 1957, 50, 499–502. [Google Scholar] [CrossRef]
  156. Fife, R.; Maclaurin, J.C.; Wright, J.H. Rescinnamine in Treatment of Hypertension in Hospital Clinic and in General Practice. Br. Med. J. 1960, 2, 1848–1850. [Google Scholar] [CrossRef] [PubMed]
  157. Stephens, D.N.; Schneider, H.H.; Kehr, W.; Andrews, J.S.; Rettig, K.J.; Turski, L.; Schmiechen, R.; Turner, J.D.; Jensen, L.H.; Petersen, E.N. Abecarnil, a Metabolically Stable, Anxioselective Beta-Carboline Acting at Benzodiazepine Receptors. J. Pharmacol. Exp. Ther. 1990, 253, 334–343. [Google Scholar]
  158. Bouwman, S.A.; Zoleko-Manego, R.; Renner, K.C.; Schmitt, E.K.; Mombo-Ngoma, G.; Grobusch, M.P. The Early Preclinical and Clinical Development of Cipargamin (KAE609), a Novel Antimalarial Compound. Travel Med. Infect. Dis. 2020, 36, 101765–101773. [Google Scholar] [CrossRef]
  159. Dai, J.; Dan, W.; Schneider, U.; Wang, J. β-Carboline Alkaloid Monomers and Dimers: Occurrence, Structural Diversity, and Biological Activities. Eur. J. Med. Chem. 2018, 157, 622–656. [Google Scholar] [CrossRef] [PubMed]
  160. Herraiz, T. Identification and Occurrence of β-Carboline Alkaloids in Raisins and Inhibition of Monoamine Oxidase (MAO). J. Agric. Food Chem. 2007, 55, 8534–8540. [Google Scholar] [CrossRef]
  161. Kumla, D.; Shine Aung, T.; Buttachon, S.; Dethoup, T.; Gales, L.; Pereira, J.A.; Inácio, Â.; Costa, P.M.; Lee, M.; Sekeroglu, N.; et al. A New Dihydrochromone Dimer and Other Secondary Metabolites from Cultures of the Marine Sponge-Associated Fungi Neosartorya Fennelliae KUFA 0811 and Neosartorya Tsunodae KUFC 9213. Mar. Drugs 2017, 15, 375. [Google Scholar] [CrossRef]
  162. Di Giorgio, C.; Delmas, F.; Ollivier, E.; Elias, R.; Balansard, G.; Timon-David, P. In Vitro Activity of the β-Carboline Alkaloids Harmane, Harmine, and Harmaline toward Parasites of the Species Leishmania Infantum. Exp. Parasitol. 2004, 106, 67–74. [Google Scholar] [CrossRef]
  163. Junwised, J.; Saiin, C.; Takasu, K. Synthesis, Cytotoxicity and in Vitro Antimalarial Activity of 1-Ethyl-Beta-Carboline; an Indole Alkaloid of Picrasma Javanica BL. In Proceedings of the 57th Kasetsart University Annual Conference: Science and Genetic Engineering, Architecture and Engineering, Agro-Industry, Natural Resources and Environment, Kasetsart University Bangkok, Bangkok, Thailand, 29 January–1 February 2019; pp. 35–42. [Google Scholar] [CrossRef]
  164. Patel, K.; Gadewar, M.; Tripathi, R.; Prasad, S.; Patel, D.K. A Review on Medicinal Importance, Pharmacological Activity and Bioanalytical Aspects of Beta-Carboline Alkaloid “Harmine”. Asian Pac. J. Trop. Biomed. 2012, 2, 660–664. [Google Scholar] [CrossRef]
  165. Kobayashi, J.; Cheng, J.F.; Ohta, T.; Nozoe, S.; Ohizumi, Y.; Sasaki, T. Eudistomidins B, C, and D: Novel Antileukemic Alkaloids from the Okinawan Marine Tunicate Eudistoma glaucus. J. Org. Chem. 1990, 55, 3666–3670. [Google Scholar] [CrossRef]
  166. Suzuki, T.; Kubota, T.; Kobayashi, J. Eudistomidins H–K, New β-Carboline Alkaloids from the Okinawan Marine Tunicate Eudistoma glaucus. Bioorg. Med. Chem. Lett. 2011, 21, 4220–4223. [Google Scholar] [CrossRef] [PubMed]
  167. Rashid, M.A.; Gustafson, K.R.; Boyd, M.R. New Cytotoxic N-Methylated Beta-Carboline Alkaloids from the Marine Ascidian Eudistoma Gilboverde. J. Nat. Prod. 2001, 64, 1454–1456. [Google Scholar] [CrossRef] [PubMed]
  168. Ibrahim, S.R.M.; Mohamed, G.A. Ingenine E, a New Cytotoxic β-Carboline Alkaloid from the Indonesian Sponge Acanthostrongylophora ingens. J. Asian Nat. Prod. Res. 2017, 19, 504–509. [Google Scholar] [CrossRef]
  169. Chan, S.T.S.; Pearce, A.N.; Page, M.J.; Kaiser, M.; Copp, B.R. Antimalarial β-Carbolines from the New Zealand Ascidian Pseudodistoma opacum. J. Nat. Prod. 2011, 74, 1972–1979. [Google Scholar] [CrossRef]
  170. Schupp, P.; Poehner, T.; Edrada, R.; Ebel, R.; Berg, A.; Wray, V.; Proksch, P. Eudistomins W and X, Two New β-Carbolines from the Micronesian Tunicate Eudistoma Sp. J. Nat. Prod. 2003, 66, 272–275. [Google Scholar] [CrossRef]
  171. Iinuma, Y.; Kozawa, S.; Ishiyama, H.; Tsuda, M.; Fukushi, E.; Kawabata, J.; Fromont, J.; Kobayashi, J. Gesashidine A, a β-Carboline Alkaloid with an Imidazole Ring from a Thorectidae Sponge. J. Nat. Prod. 2005, 68, 1109–1110. [Google Scholar] [CrossRef]
  172. Ibrahim, S.; Mohamed, G.; Al Haidari, R.; El-Kholy, A.; Zayed, M. Ingenine F: A New Cytotoxic Tetrahydro Carboline Alkaloid from the Indonesian Marine Sponge Acanthostrongylophora ingens. Pharmacogn. Mag. 2018, 14, 231–234. [Google Scholar] [CrossRef]
  173. Davis, R.A.; Duffy, S.; Avery, V.M.; Camp, D.; Hooper, J.N.A.; Quinn, R.J. (+)-7-Bromotrypargine: An Antimalarial β-Carboline from the Australian Marine Sponge Ancorina Sp. Tetrahedron Lett. 2010, 51, 583–585. [Google Scholar] [CrossRef]
  174. Patil, A.D.; Freyer, A.J.; Carte, B.; Taylor, P.B.; Johnson, R.K.; Faulkner, D.J. Haploscleridamine, a Novel Tryptamine-Derived Alkaloid from a Sponge of the Order Haplosclerida:  An Inhibitor of Cathepsin K. J. Nat. Prod. 2002, 65, 628–629. [Google Scholar] [CrossRef]
  175. Tanaka, N.; Momose, R.; Takahashi-Nakaguchi, A.; Gonoi, T.; Fromont, J.; Kobayashi, J. Hyrtimomines, Indole Alkaloids from Okinawan Marine Sponges Hyrtios Spp. Tetrahedron 2014, 70, 832–837. [Google Scholar] [CrossRef]
  176. Prinsep, M.R.; Blunt, J.W.; Munro, M.H. New Cytotoxic Beta-Carboline Alkaloids from the Marine Bryozoan, Cribricellina cribraria. J. Nat. Prod. 1991, 54, 1068–1076. [Google Scholar] [CrossRef]
  177. Yan, W.; Zhao, S.S.; Ye, Y.H.; Zhang, Y.Y.; Zhang, Y.; Xu, J.Y.; Yin, S.M.; Tan, R.X. Generation of Indoles with Agrochemical Significance through Biotransformation by Chaetomium globosum. J. Nat. Prod. 2019, 82, 2132–2137. [Google Scholar] [CrossRef]
  178. Shi, Y.; Xu, Z.; Tan, R.; Lei, X. Divergent Total Synthesis of Chaetoglines C to F. J. Org. Chem. 2019, 84, 8766–8770. [Google Scholar] [CrossRef]
  179. Yan, W.; Ge, H.M.; Wang, G.; Jiang, N.; Mei, Y.N.; Jiang, R.; Li, S.J.; Chen, C.J.; Jiao, R.H.; Xu, Q.; et al. Pictet–Spengler Reaction-Based Biosynthetic Machinery in Fungi. Proc. Natl. Acad. Sci. USA 2014, 111, 18138–18143. [Google Scholar] [CrossRef]
  180. Gohil, V.M.; Brahmbhatt, K.G.; Loiseau, P.M.; Bhutani, K.K. Synthesis and Anti-Leishmanial Activity of 1-Aryl-β-Carboline Derivatives against Leishmania Donovani. Bioorg. Med. Chem. Lett. 2012, 22, 3905–3907. [Google Scholar] [CrossRef] [PubMed]
  181. Kong, Y.; Wang, L.-H.; Liu, L.; Zheng, L.-H.; Bao, Y.-L.; Liu, X.-X.; Wang, S.-Y.; Song, Z.-B. Immunomodulatory Effects of Flazin from Crassostrea sikamea on Splenic Lymphocytes of Sprague-Dawley Rats. Chin. J. Nat. Med. 2021, 19, 836–843. [Google Scholar] [CrossRef] [PubMed]
  182. Tang, J.-G.; Wang, Y.-H.; Wang, R.-R.; Dong, Z.-J.; Yang, L.-M.; Zheng, Y.-T.; Liu, J.-K. Synthesis of Analogues of Flazin, in Particular, Flazinamide, as Promising Anti-HIV Agents. Chem. Biodivers. 2008, 5, 447–460. [Google Scholar] [CrossRef] [PubMed]
  183. Kobayashi, J.; Harbour, G.C.; Gilmore, J.; Rinehart, K.L., Jr. Eudistomins A, D, G, H, I, J, M, N, O, P, and Q, Bromo, Hydroxy, Pyrrolyl and Iminoazepino .Beta.-Carbolines from the Antiviral Caribbean Tunicate Eudistoma Olivaceum. J. Am. Chem. Soc. 1984, 106, 1526–1528. [Google Scholar] [CrossRef]
  184. VanWagenen, B.C.; Cardellina, J.H. Short, Efficient Syntheses of the Antibiotic Eudistomins I and T. Tetrahedron Lett. 1989, 30, 3605–3608. [Google Scholar] [CrossRef]
  185. Rajesh, R.P.; Murugan, A. Spectroscopic Identification of Brominated, Non-Brominated Alkaloids and Evaluation of Antimicrobial Activity of Eudistomin-I, Eudistomin H, from Green Ascidian Eudistoma viride. J. Appl. Pharm. Sci. 2019, 9, 116–123. [Google Scholar] [CrossRef]
  186. Kolodina, A.A.; OV, S.A. Eudistomin U, Isoeudistomin U, and Related Indole Compounds: Synthesis and Biological Activity. Heterocycles 2018, 96, 1171. [Google Scholar] [CrossRef]
  187. Ibrahim, S.R.M.; Mohamed, G.A. Ingenines C and D, New Cytotoxic Pyrimidine-β-Carboline Alkaloids from the Indonesian Sponge Acanthostrongylophora ingens. Phytochem. Lett. 2016, 18, 168–171. [Google Scholar] [CrossRef]
  188. Dhaneesha, M.; Umar, M.; Merlin, T.S.; Krishnan, K.P.; Sukumaran, V.; Sinha, R.K.; Anas, A.; Fu, P.; MacMillan, J.B.; Sajeevan, T.P. Pseudonocardia cytotoxica Sp. Nov., a Novel Actinomycete Isolated from an Arctic Fjord with Potential to Produce Cytotoxic Compound. Antonie Van Leeuwenhoek 2021, 114, 23–35. [Google Scholar] [CrossRef] [PubMed]
  189. Shin, H.J.; Lee, H.-S.; Lee, D.-S. The Synergistic Antibacterial Activity of 1-Acetyl-Beta-Carboline and Beta-Lactams against Methicillin-Resistant Staphylococcus aureus (MRSA). J. Microbiol. Biotechnol. 2010, 20, 501–505. [Google Scholar] [PubMed]
  190. Li, J.; Tang, Y.; Jin, H.-J.; Cui, Y.-D.; Zhang, L.-J.; Jiang, T. An Efficient Synthesis Method Targeted to Marine Alkaloids Marinacarbolines A–D and Their Antitumor Activities. J. Asian Nat. Prod. Res. 2015, 17, 299–305. [Google Scholar] [CrossRef] [PubMed]
  191. Byun, W.S.; Lim, H.; Hong, J.; Bae, E.S.; Lee, S.B.; Kim, Y.; Lee, J.; Lee, S.K.; Hong, S. Design, Synthesis, and Biological Activity of Marinacarboline Analogues as STAT3 Pathway Inhibitors for Docetaxel-Resistant Triple-Negative Breast Cancer. J. Med. Chem. 2023, 66, 3106–3133. [Google Scholar] [CrossRef] [PubMed]
  192. Won, T.H.; Jeon, J.; Lee, S.-H.; Rho, B.J.; Oh, K.-B.; Shin, J. Beta-Carboline Alkaloids Derived from the Ascidian Synoicum Sp. Bioorg. Med. Chem. 2012, 20, 4082–4087. [Google Scholar] [CrossRef] [PubMed]
  193. Wang, W.; Nam, S.-J.; Lee, B.-C.; Kang, H. β-Carboline Alkaloids from a Korean Tunicate Eudistoma Sp. J. Nat. Prod. 2008, 71, 163–166. [Google Scholar] [CrossRef]
  194. Jin, H.; Zhang, P.; Bijian, K.; Ren, S.; Wan, S.; Alaoui-Jamali, M.A.; Jiang, T. Total Synthesis and Biological Activity of Marine Alkaloid Eudistomins Y1–Y7 and Their Analogues. Mar. Drugs 2013, 11, 1427–1439. [Google Scholar] [CrossRef]
  195. Yang, G.; Xie, H.; Wang, C.; Zhang, C.; Yu, L.; Zhang, L.; Liu, X.; Xu, R.; Song, Z.; Liu, R.; et al. Design, Synthesis, and Discovery of Eudistomin Y Derivatives as Lysosome-Targeted Antiproliferation Agents. Eur. J. Med. Chem. 2023, 250, 115193–115204. [Google Scholar] [CrossRef]
  196. Peng, J.; Hu, J.-F.; Kazi, A.B.; Li, Z.; Avery, M.; Peraud, O.; Hill, R.T.; Franzblau, S.G.; Zhang, F.; Schinazi, R.F.; et al. Manadomanzamines A and B: A Novel Alkaloid Ring System with Potent Activity against Mycobacteria and HIV-1. J. Am. Chem. Soc. 2003, 125, 13382–13386. [Google Scholar] [CrossRef] [PubMed]
  197. Inman, W.D.; Bray, W.M.; Gassner, N.C.; Lokey, R.S.; Tenney, K.; Shen, Y.Y.; TenDyke, K.; Suh, T.; Crews, P. A β-Carboline Alkaloid from the Papua New Guinea Marine Sponge Hyrtios reticulatus. J. Nat. Prod. 2010, 73, 255–257. [Google Scholar] [CrossRef] [PubMed]
  198. Bourguet-Kondracki, M.L.; Martin, M.T.; Guyot, M. A New β-Carboline Alkaloid Isolated from the Marine Sponge Hyrtios erecta. Tetrahedron Lett. 1996, 37, 3457–3460. [Google Scholar] [CrossRef]
  199. Szabó, T.; Dancsó, A.; Volk, B.; Milen, M. First Total Synthesis of β-Carboline Alkaloid Trigonostemine G and Its Derivatives. Nat. Prod. Res. 2021, 35, 72–79. [Google Scholar] [CrossRef] [PubMed]
  200. Zhang, P.; Sun, X.; Xu, B.; Bijian, K.; Wan, S.; Li, G.; Alaoui-Jamali, M.; Jiang, T. Total Synthesis and Bioactivity of the Marine Alkaloid Pityriacitrin and Some of Its Derivatives. Eur. J. Med. Chem. 2011, 46, 6089–6097. [Google Scholar] [CrossRef] [PubMed]
  201. Li, Y.; Zhang, J.-J.; Xu, D.-P.; Zhou, T.; Zhou, Y.; Li, S.; Li, H.-B. Bioactivities and Health Benefits of Wild Fruits. Int. J. Mol. Sci. 2016, 17, 1258. [Google Scholar] [CrossRef] [PubMed]
  202. Sauleau, P.; Martin, M.-T.; Dau, M.-E.T.H.; Youssef, D.T.A.; Bourguet-Kondracki, M.-L. Hyrtiazepine, an Azepino-Indole-Type Alkaloid from the Red Sea Marine Sponge Hyrtios erectus. J. Nat. Prod. 2006, 69, 1676–1679. [Google Scholar] [CrossRef]
  203. Kashtoh, H.; Baek, K.-H. Recent Updates on Phytoconstituent Alpha-Glucosidase Inhibitors: An Approach towards the Treatment of Type Two Diabetes. Plants 2022, 11, 2722. [Google Scholar] [CrossRef]
  204. Ha, N.T.T.; Quan, P.M.; Van Tuyen, N.; Tra, N.T.; Anh, L.T.T.; Son, N.T. Chemical Constituents of Alocasia Odora Rhizomes and Their Biological Activities: Experimental and Molecular Docking Approaches. Rev. Bras. Farmacogn. 2022, 32, 819–826. [Google Scholar] [CrossRef]
  205. Liew, L.P.P.; Fleming, J.M.; Longeon, A.; Mouray, E.; Florent, I.; Bourguet-Kondracki, M.-L.; Copp, B.R. Synthesis of 1-Indolyl Substituted β-Carboline Natural Products and Discovery of Antimalarial and Cytotoxic Activities. Tetrahedron 2014, 70, 4910–4920. [Google Scholar] [CrossRef]
  206. Pereira, M.D.; da Silva, T.; Aguiar, A.C.C.; Oliva, G.; Guido, R.V.; Yokoyama-Yasunaka, J.K.; Uliana, S.R.; Lopes, L.M. Chemical Composition, Antiprotozoal and Cytotoxic Activities of Indole Alkaloids and Benzofuran Neolignan of Aristolochia cordigera. Planta Med. 2017, 83, 912–920. [Google Scholar] [CrossRef]
  207. Oku, N.; Matsunaga, S.; Fusetani, N. Shishijimicins A−C, Novel Enediyne Antitumor Antibiotics from the Ascidian Didemnum Proliferum. J. Am. Chem. Soc. 2003, 125, 2044–2045. [Google Scholar] [CrossRef]
  208. Nicolaou, K.C.; Lu, Z.; Li, R.; Woods, J.R.; Sohn, T. Total Synthesis of Shishijimicin A. J. Am. Chem. Soc. 2015, 137, 8716–8719. [Google Scholar] [CrossRef]
  209. Nakamura, H.; Deng, S.; Kobayashi, J.; Ohizumi, Y.; Tomotake, Y.; Matsuzaki, T.; Hirata, Y. Keramamine-A and -B, Novel Antimicrobial Alkaloids from the Okinawan Marine Sponge Pellina Sp. Tetrahedron Lett. 1987, 28, 621–624. [Google Scholar] [CrossRef]
  210. Sakai, R.; Higa, T.; Jefford, C.W.; Bernardinelli, G. Manzamine A, a Novel Antitumor Alkaloid from a Sponge. J. Am. Chem. Soc. 1986, 108, 6404–6405. [Google Scholar] [CrossRef]
  211. Rao, K.V.; Kasanah, N.; Wahyuono, S.; Tekwani, B.L.; Schinazi, R.F.; Hamann, M.T. Three New Manzamine Alkaloids from a Common Indonesian Sponge and Their Activity against Infectious and Tropical Parasitic Diseases. J. Nat. Prod. 2004, 67, 1314–1318. [Google Scholar] [CrossRef] [PubMed]
  212. Lin, L.-C.; Kuo, T.-T.; Chang, H.-Y.; Liu, W.-S.; Hsia, S.-M.; Huang, T.-C. Manzamine A Exerts Anticancer Activity against Human Colorectal Cancer Cells. Mar. Drugs 2018, 16, 252. [Google Scholar] [CrossRef] [PubMed]
  213. Kallifatidis, G.; Hoepfner, D.; Jaeg, T.; Guzmán, E.A.; Wright, A.E. The Marine Natural Product Manzamine A Targets Vacuolar ATPases and Inhibits Autophagy in Pancreatic Cancer Cells. Mar. Drugs 2013, 11, 3500–3516. [Google Scholar] [CrossRef] [PubMed]
  214. Hamann, M.; Alonso, D.; Martín-Aparicio, E.; Fuertes, A.; Pérez-Puerto, M.J.; Castro, A.; Morales, S.; Navarro, M.L.; del Monte-Millán, M.; Medina, M.; et al. Glycogen Synthase Kinase-3 (GSK-3) Inhibitory Activity and Structure–Activity Relationship (SAR) Studies of the Manzamine Alkaloids. Potential for Alzheimer’s Disease. J. Nat. Prod. 2007, 70, 1397–1405. [Google Scholar] [CrossRef]
  215. Palem, J.R.; Mudit, M.; Hsia, S.V.; Sayed, K.A.E. Discovery and Preliminary Structure-Activity Relationship of the Marine Natural Product Manzamines as Herpes Simplex Virus Type-1 Inhibitors. Z. Naturforschung C 2017, 72, 49–54. [Google Scholar] [CrossRef] [PubMed]
  216. Ichiba, T.; Corgiat, J.M.; Scheuer, P.J.; Kelly-Borges, M. 8-Hydroxymanzamine A, a Beta-Carboline Alkaloid from a Sponge, Pachypellina Sp. J. Nat. Prod. 1994, 57, 168–170. [Google Scholar] [CrossRef] [PubMed]
  217. Ashok, P.; Ganguly, S.; Murugesan, S. Manzamine Alkaloids: Isolation, Cytotoxicity, Antimalarial Activity and SAR Studies. Drug Discov. Today 2014, 19, 1781–1791. [Google Scholar] [CrossRef] [PubMed]
  218. El Sayed, K.A.; Kelly, M.; Kara, U.A.K.; Ang, K.K.H.; Katsuyama, I.; Dunbar, D.C.; Khan, A.A.; Hamann, M.T. New Manzamine Alkaloids with Potent Activity against Infectious Diseases. J. Am. Chem. Soc. 2001, 123, 1804–1808. [Google Scholar] [CrossRef] [PubMed]
  219. Watanabe, D.; Tsuda, M.; Kobayashi, J. Three New Manzamine Congeners from Amphimedon Sponge. J. Nat. Prod. 1998, 61, 689–692. [Google Scholar] [CrossRef] [PubMed]
  220. Yousaf, M.; El Sayed, K.A.; Rao, K.V.; Lim, C.W.; Hu, J.-F.; Kelly, M.; Franzblau, S.G.; Zhang, F.; Peraud, O.; Hill, R.T.; et al. 12,34-Oxamanzamines, Novel Biocatalytic and Natural Products from Manzamine Producing Indo-Pacific Sponges. Tetrahedron 2002, 58, 7397–7402. [Google Scholar] [CrossRef]
  221. Yousaf, M.; Hammond, N.L.; Peng, J.; Wahyuono, S.; McIntosh, K.A.; Charman, W.N.; Mayer, A.M.S.; Hamann, M.T. New Manzamine Alkaloids from an Indo-Pacific Sponge. Pharmacokinetics, Oral Availability, and the Significant Activity of Several Manzamines against HIV-I, AIDS Opportunistic Infections, and Inflammatory Diseases. J. Med. Chem. 2004, 47, 3512–3517. [Google Scholar] [CrossRef] [PubMed]
  222. Crews, P.; Cheng, X.-C.; Adamczeski, M.; Rodríguez, J.; Jaspars, M.; Schmitz, F.J.; Traeger, S.C.; Pordesimo, E.O. 1,2,3,4-Tetrahydro-8-Hydroxymanzamines, Alkaloids from Two Different Haplosclerid Sponges. Tetrahedron 1994, 50, 13567–13574. [Google Scholar] [CrossRef]
  223. Ichiba, T.; Sakai, R.; Kohmoto, S.; Saucy, G.; Higa, T. New Manzamine Alkaloids from a Sponge of the Genus Xestospongia. Tetrahedron Lett. 1988, 29, 3083–3086. [Google Scholar] [CrossRef]
  224. El-Desoky, A.H.; Kato, H.; Eguchi, K.; Kawabata, T.; Fujiwara, Y.; Losung, F.; Mangindaan, R.E.P.; de Voogd, N.J.; Takeya, M.; Yokosawa, H.; et al. Acantholactam and Pre-Neo-Kauluamine, Manzamine-Related Alkaloids from the Indonesian Marine Sponge Acanthostrongylophora ingens. J. Nat. Prod. 2014, 77, 1536–1540. [Google Scholar] [CrossRef]
  225. Yamada, M.; Takahashi, Y.; Kubota, T.; Fromont, J.; Ishiyama, A.; Otoguro, K.; Yamada, H.; Ōmura, S.; Kobayashi, J.I. Zamamidine C, 3,4-Dihydro-6-Hydroxy-10,11-Epoxymanzamine A, and 3,4-Dihydromanzamine J N-Oxide, New Manzamine Alkaloids from Sponge Amphimedon Sp. Tetrahedron 2009, 65, 2313–2317. [Google Scholar] [CrossRef]
  226. Kim, C.-K.; Riswanto, R.; Won, T.H.; Kim, H.; Elya, B.; Sim, C.J.; Oh, D.-C.; Oh, K.-B.; Shin, J. Manzamine Alkaloids from an Acanthostrongylophora Sp. Sponge. J. Nat. Prod. 2017, 80, 1575–1583. [Google Scholar] [CrossRef]
  227. Furusato, A.; Kato, H.; Nehira, T.; Eguchi, K.; Kawabata, T.; Fujiwara, Y.; Losung, F.; Mangindaan, R.E.P.; de Voogd, N.J.; Takeya, M.; et al. Acanthomanzamines A–E with New Manzamine Frameworks from the Marine Sponge Acanthostrongylophora ingens. Org. Lett. 2014, 16, 3888–3891. [Google Scholar] [CrossRef]
  228. Tsuda, M.; Watanabe, D.; Kobayashi, J. Ma’eganedin A, a New Manzamine Alkaloid from Amphimedon Sponge. Tetrahedron Lett. 1998, 39, 1207–1210. [Google Scholar] [CrossRef]
  229. Longley, R.E.; McConnell, O.J.; Essich, E.; Harmody, D. Evaluation of Marine Sponge Metabolites for Cytotoxicity and Signal Transduction Activity. J. Nat. Prod. 1993, 56, 915–920. [Google Scholar] [CrossRef] [PubMed]
  230. Kobayashi, M.; Chen, Y.-J.; Aoki, S.; In, Y.; Ishida, T.; Kitagawa, I. Four New β-Carboline Alkaloids Isolated from Two Okinawan Marine Sponges of Xestospongia Sp. and Haliclona Sp. Tetrahedron 1995, 51, 3727–3736. [Google Scholar] [CrossRef]
  231. Edrada, R.A.; Proksch, P.; Wray, V.; Witte, L.; Müller, W.E.G.; Van Soest, R.W.M. Four New Bioactive Manzamine-Type Alkaloids from the Philippine Marine Sponge Xestospongia Ashmorica. J. Nat. Prod. 1996, 59, 1056–1060. [Google Scholar] [CrossRef] [PubMed]
  232. Tadokoro, Y.; Nishikawa, T.; Ichimori, T.; Matsunaga, S.; Fujita, M.J.; Sakai, R. N-Methyl-β-Carbolinium Salts and an N-Methylated 8-Oxoisoguanine as Acetylcholinesterase Inhibitors from a Solitary Ascidian, Cnemidocarpa Irene. ACS Omega 2017, 2, 1074–1080. [Google Scholar] [CrossRef] [PubMed]
  233. Segraves, N.L.; Lopez, S.; Johnson, T.A.; Said, S.A.; Fu, X.; Schmitz, F.J.; Pietraszkiewicz, H.; Valeriote, F.A.; Crews, P. Structures and Cytotoxicities of Fascaplysin and Related Alkaloids from Two Marine Phyla—Fascaplysinopsis Sponges and Didemnum Tunicates. Tetrahedron Lett. 2003, 44, 3471–3475. [Google Scholar] [CrossRef]
  234. Izzati, F.; Warsito, M.F.; Bayu, A.; Prasetyoputri, A.; Atikana, A.; Sukmarini, L.; Rahmawati, S.I.; Putra, M.Y. Chemical Diversity and Biological Activity of Secondary Metabolites Isolated from Indonesian Marine Invertebrates. Molecules 2021, 26, 1898. [Google Scholar] [CrossRef] [PubMed]
  235. Tran, T.D.; Pham, N.B.; Ekins, M.; Hooper, J.N.A.; Quinn, R.J. Isolation and Total Synthesis of Stolonines A–C, Unique Taurine Amides from the Australian Marine Tunicate Cnemidocarpa Stolonifera. Mar. Drugs 2015, 13, 4556–4575. [Google Scholar] [CrossRef] [PubMed]
  236. Ravinder, K.; Vijender Reddy, A.; Krishnaiah, P.; Ramesh, P.; Ramakrishna, S.; Laatsch, H.; Venkateswarlu, Y. Isolation and Synthesis of a Novel β-Carboline Guanidine Derivative Tiruchanduramine from the Indian Ascidian Synoicum Macroglossum. Tetrahedron Lett. 2005, 46, 5475–5478. [Google Scholar] [CrossRef]
  237. Youssef, D.T.A. Hyrtioerectines A−C, Cytotoxic Alkaloids from the Red Sea Sponge Hyrtios erectus. J. Nat. Prod. 2005, 68, 1416–1419. [Google Scholar] [CrossRef]
  238. Wang, C.; Wang, S.; Li, H.; Hou, Y.; Cao, H.; Hua, H.; Li, D. Marine-Derived Lead Fascaplysin: Pharmacological Activity, Total Synthesis, and Structural Modification. Mar. Drugs 2023, 21, 226. [Google Scholar] [CrossRef] [PubMed]
  239. Charan, R.D.; McKee, T.C.; Gustafson, K.R.; Pannell, L.K.; Boyd, M.R. Thorectandramine, a Novel β-Carboline Alkaloid from the Marine Sponge Thorectandra Sp. Tetrahedron Lett. 2002, 43, 5201–5204. [Google Scholar] [CrossRef]
  240. Lake, R.J.; Blunt, J.W.; Munro, M.H.G. Eudistomins From the New Zealand Ascidian Ritterella sigillinoides. Aust. J. Chem. 1989, 42, 1201–1206. [Google Scholar] [CrossRef]
  241. Chatwichien, J.; Basu, S.; Murphy, M.E.; Hamann, M.T.; Winkler, J.D. Design, Synthesis, and Biological Evaluation of β-Carboline Dimers Based on the Structure of Neokauluamine. Tetrahedron Lett. 2015, 56, 3515–3517. [Google Scholar] [CrossRef]
  242. Suzuki, K.; Nomura, I.; Ninomiya, M.; Tanaka, K.; Koketsu, M. Synthesis and Antimicrobial Activity of β-Carboline Derivatives with N2-Alkyl Modifications. Bioorg. Med. Chem. Lett. 2018, 28, 2976–2978. [Google Scholar] [CrossRef]
  243. Ohtani, I.I.; Ichiba, T.; Isobe, M.; Kelly-Borges, M.; Scheuer, P.J. Kauluamine, an Unprecedented Manzamine Dimer from an Indonesian Marine Sponge, Prianos Sp. J. Am. Chem. Soc. 1995, 117, 10743–10744. [Google Scholar] [CrossRef]
  244. Zulkifli, S.Z.; Pungot, N.H.; Saaidin, A.S.; Jani, N.A.; Mohammat, M.F. Synthesis and Diverse Biological Activities of Substituted Indole β-Carbolines: A Review. Nat. Prod. Res. 2023, 28, 1–14. [Google Scholar] [CrossRef] [PubMed]
  245. Dalpozzo, R. The Chiral Pool in the Pictet–Spengler Reaction for the Synthesis of β-Carbolines. Molecules 2016, 21, 699. [Google Scholar] [CrossRef] [PubMed]
  246. Pakhare, D.S.; Kusurkar, R.S. Synthesis of Tetrahydro-β-Carbolines, β-Carbolines, and Natural Products, (±)-Harmicine, Eudistomin U and Canthine by Reductive Pictet Spengler Cyclization. Tetrahedron Lett. 2015, 56, 6012–6015. [Google Scholar] [CrossRef]
  247. Whaley, W.M.; Govindachari, T.R. The Preparation of 3,4-Dihydroisoquinolines and Related Compounds by the Bischler-Napieralski Reaction. In Organic Reactions; John Wiley & Sons, Ltd.: Hoboken, NJ, USA, 2011; Volume 65, pp. 74–150. ISBN 978-0-471-26418-7. [Google Scholar] [CrossRef]
  248. Hibino, S.; Sugino, E.; Yamochi, T.; Kuwata, M.; Hashimoto, H.; Sato, K.; Amanuma, F.; Karasaw, Y. Syntheses and Sleeping-Time-Prolonging Effect of Nitramarine and Related Compounds. Chem. Pharm. Bull. 1987, 35, 2261–2265. [Google Scholar] [CrossRef]
  249. Broeck, P.V.; Doren, P.V.; Hoornaert, G. Reaction of 3H-Pyrano[3,4-b]Indol-3-Ones and 3H-2-Benzopyran-3-Ones with Heterodienophiles: A Two Step Synthesis for Some 9H-Pyrido[3,4-b]Indoles and Isoquinolines. Synthesis 1992, 1992, 473–476. [Google Scholar] [CrossRef]
  250. Iwaki, T.; Yasuhara, A.; Sakamoto, T. Novel Synthetic Strategy of Carbolines via Palladium-Catalyzed Amination and Arylation Reaction. J. Chem. Soc. Perkin Trans. 1 1999, 1505–1510. [Google Scholar] [CrossRef]
  251. Smith, P.A.S.; Boyer, J.H. The Synthesis of Heterocyclic Compounds from Aryl Azides. II. Carbolines and Thienoindole1. J. Am. Chem. Soc. 1951, 73, 2626–2629. [Google Scholar] [CrossRef]
  252. Rocca, P.; Marsais, F.; Godard, A.; Queguiner, G. Connection between Metalation and Cross-Coupling Strategies. A New Convergent Route to Azacarbazoles. Tetrahedron 1993, 49, 49–64. [Google Scholar] [CrossRef]
  253. Clark, V.M.; Cox, A.; Herbert, E.J. The Photocyclisation of Anilino-Pyridines to Carbolines. J. Chem. Soc. C Org. 1968, 831–833. [Google Scholar] [CrossRef]
  254. Arshad, A.S.M.; Mordi, M.N. Carboline Regioisomers Based on Unified Synthetic Approaches. Adv. Synth. Catal. 2023, 365, 2126–2146. [Google Scholar] [CrossRef]
  255. Devi, N.; Kumar, S.; Pandey, S.K.; Singh, V. 1(3)-Formyl-β-Carbolines: Potential Aldo-X Precursors for the Synthesis of β-Carboline-Based Molecular Architectures. Asian J. Org. Chem. 2018, 7, 6–36. [Google Scholar] [CrossRef]
  256. Qi, S.-H.; Su, G.-C.; Wang, Y.-F.; Liu, Q.-Y.; Gao, C.-H. Alkaloids from the South China Sea Black Coral Antipathes dichotoma. Chem. Pharm. Bull. 2009, 57, 87–88. [Google Scholar] [CrossRef]
  257. Lyakhova, E.G.; Kolesnikova, S.A.; Kalinovsky, A.I.; Afiyatullov, S.S.; Dyshlovoy, S.A.; Krasokhin, V.B.; Minh, C.V.; Stonik, V.A. Bromine-Containing Alkaloids from the Marine Sponge Penares Sp. Tetrahedron Lett. 2012, 53, 6119–6122. [Google Scholar] [CrossRef]
  258. Gui, T.; Lin, S.; Wang, Z.; Fu, P.; Wang, C.; Zhu, W. Cytotoxic Indolocarbazoles From a Marine-Derived Streptomyces Sp. OUCMDZ-5380. Front. Microbiol. 2022, 13, 957473. [Google Scholar] [CrossRef]
  259. Choi, E.J.; Park, J.S.; Kim, Y.J.; Jung, J.H.; Lee, J.K.; Kwon, H.C.; Yang, H.O. Apoptosis-inducing Effect of Diketopiperazine Disulfides Produced by Aspergillus Sp. KMD 901 Isolated from Marine Sediment on HCT116 Colon Cancer Cell Lines. J. Appl. Microbiol. 2011, 110, 304–313. [Google Scholar] [CrossRef] [PubMed]
  260. Kong, F.; Wang, Y.; Liu, P.; Dong, T.; Zhu, W. Thiodiketopiperazines from the Marine-Derived Fungus Phoma Sp. OUCMDZ-1847. J. Nat. Prod. 2014, 77, 132–137. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Example of marine drugs accepted by the FDA.
Figure 1. Example of marine drugs accepted by the FDA.
Marinedrugs 22 00126 g001
Figure 2. Structure/activity relationships of indole derivatives.
Figure 2. Structure/activity relationships of indole derivatives.
Marinedrugs 22 00126 g002
Figure 3. Structure of some marine indole alkaloids with anticancer activity.
Figure 3. Structure of some marine indole alkaloids with anticancer activity.
Marinedrugs 22 00126 g003
Figure 4. Structures of C3-acyclic substituted SIAs 15.
Figure 4. Structures of C3-acyclic substituted SIAs 15.
Marinedrugs 22 00126 g004
Figure 5. Structures of C3-carbaldehyde/carboxy-substituted SIAs 610.
Figure 5. Structures of C3-carbaldehyde/carboxy-substituted SIAs 610.
Marinedrugs 22 00126 g005
Figure 6. Biogenetic route to obtain Anthranoside C (11).
Figure 6. Biogenetic route to obtain Anthranoside C (11).
Marinedrugs 22 00126 g006
Figure 7. Structures of prenylated SIAs 1417.
Figure 7. Structures of prenylated SIAs 1417.
Marinedrugs 22 00126 g007
Figure 8. Biogenesis of isomers 18 and 19.
Figure 8. Biogenesis of isomers 18 and 19.
Marinedrugs 22 00126 g008
Figure 9. Synthetic approaches in the preparation of functionalized SIAs.
Figure 9. Synthetic approaches in the preparation of functionalized SIAs.
Marinedrugs 22 00126 g009
Figure 10. Trachycladindole A–G (2632), aplysinopsins (33), and their derivatives (3440).
Figure 10. Trachycladindole A–G (2632), aplysinopsins (33), and their derivatives (3440).
Marinedrugs 22 00126 g010
Figure 11. Trachycladindole hypothetical biosynthesis by A. Hentz.
Figure 11. Trachycladindole hypothetical biosynthesis by A. Hentz.
Marinedrugs 22 00126 g011
Figure 12. Stanovnik and Svete’s synthesis of Aplysinopsin derivate 39.
Figure 12. Stanovnik and Svete’s synthesis of Aplysinopsin derivate 39.
Marinedrugs 22 00126 g012
Figure 13. Structure of Meridianins A–G (4147).
Figure 13. Structure of Meridianins A–G (4147).
Marinedrugs 22 00126 g013
Figure 14. Jing and Yang synthesis of Meridianin D (44).
Figure 14. Jing and Yang synthesis of Meridianin D (44).
Marinedrugs 22 00126 g014
Figure 15. Fresneda and Molina’s synthesis of Meridianins C (43) and D (44).
Figure 15. Fresneda and Molina’s synthesis of Meridianins C (43) and D (44).
Marinedrugs 22 00126 g015
Figure 16. Structure of bis-indoles 5053 and tris-indole 54.
Figure 16. Structure of bis-indoles 5053 and tris-indole 54.
Marinedrugs 22 00126 g016
Figure 17. Structure of bromodeoxytopsentin (55) and dibromodeoxytopsentin (56).
Figure 17. Structure of bromodeoxytopsentin (55) and dibromodeoxytopsentin (56).
Marinedrugs 22 00126 g017
Figure 18. Structure of eusynstelamides A–B and D–F (5761).
Figure 18. Structure of eusynstelamides A–B and D–F (5761).
Marinedrugs 22 00126 g018
Figure 19. Structure of Hamacanthins A–B (6263).
Figure 19. Structure of Hamacanthins A–B (6263).
Marinedrugs 22 00126 g019
Figure 20. Janosik et al. [64] synthesis of Rhopaladin C (53).
Figure 20. Janosik et al. [64] synthesis of Rhopaladin C (53).
Marinedrugs 22 00126 g020
Figure 21. Basic structures of Simple Diketopiperazines.
Figure 21. Basic structures of Simple Diketopiperazines.
Marinedrugs 22 00126 g021
Figure 22. Chemical structures of simple DKPs 6468 with C3-methylene bridge.
Figure 22. Chemical structures of simple DKPs 6468 with C3-methylene bridge.
Marinedrugs 22 00126 g022
Figure 23. Chemical structures of simple DKPs 6982 with C3-methylene bridge.
Figure 23. Chemical structures of simple DKPs 6982 with C3-methylene bridge.
Marinedrugs 22 00126 g023
Figure 24. Chemical structures of simple DKPs 83102 with C3-ethylidene bridge.
Figure 24. Chemical structures of simple DKPs 83102 with C3-ethylidene bridge.
Marinedrugs 22 00126 g024
Figure 25. Chemical structures of bis-indol DKPs 103105.
Figure 25. Chemical structures of bis-indol DKPs 103105.
Marinedrugs 22 00126 g025
Figure 26. Possible disconnections of a 2,5-diketopiperazine ring.
Figure 26. Possible disconnections of a 2,5-diketopiperazine ring.
Marinedrugs 22 00126 g026
Figure 27. Aza-Wittig cyclization to synthesize DKPs 107.
Figure 27. Aza-Wittig cyclization to synthesize DKPs 107.
Marinedrugs 22 00126 g027
Figure 28. Synthesis and biosynthesis of Brevianamide F (64).
Figure 28. Synthesis and biosynthesis of Brevianamide F (64).
Marinedrugs 22 00126 g028
Figure 29. Synthesis of Neochenulin A (94).
Figure 29. Synthesis of Neochenulin A (94).
Marinedrugs 22 00126 g029
Figure 30. Synthesis of Aspergilazine A (103).
Figure 30. Synthesis of Aspergilazine A (103).
Marinedrugs 22 00126 g030
Figure 31. Structures of compounds 113118.
Figure 31. Structures of compounds 113118.
Marinedrugs 22 00126 g031
Figure 32. Structures of compounds 119129.
Figure 32. Structures of compounds 119129.
Marinedrugs 22 00126 g032
Figure 33. Example of synthesis of breviamides 132135.
Figure 33. Example of synthesis of breviamides 132135.
Marinedrugs 22 00126 g033
Figure 34. Synthesis of dimethyhydropyranoindole nucleus.
Figure 34. Synthesis of dimethyhydropyranoindole nucleus.
Marinedrugs 22 00126 g034
Figure 35. Structures of compounds 136146.
Figure 35. Structures of compounds 136146.
Marinedrugs 22 00126 g035
Figure 36. Structures of compounds 147165.
Figure 36. Structures of compounds 147165.
Marinedrugs 22 00126 g036
Figure 37. Synthesis of Indole diketopiperazine alkaloids.
Figure 37. Synthesis of Indole diketopiperazine alkaloids.
Marinedrugs 22 00126 g037
Figure 38. Structures of compounds 173 and 174.
Figure 38. Structures of compounds 173 and 174.
Marinedrugs 22 00126 g038
Figure 39. Classical synthesis of Flustramine C (178).
Figure 39. Classical synthesis of Flustramine C (178).
Marinedrugs 22 00126 g039
Figure 40. Synthesis of the flustramines analogs 179.
Figure 40. Synthesis of the flustramines analogs 179.
Marinedrugs 22 00126 g040
Figure 41. Synthetic routes of tricyclic HPI.
Figure 41. Synthetic routes of tricyclic HPI.
Marinedrugs 22 00126 g041
Figure 42. Structures of compounds 182185.
Figure 42. Structures of compounds 182185.
Marinedrugs 22 00126 g042
Figure 43. Structures of compounds 186203.
Figure 43. Structures of compounds 186203.
Marinedrugs 22 00126 g043
Figure 44. Structures of compounds 204206.
Figure 44. Structures of compounds 204206.
Marinedrugs 22 00126 g044
Figure 45. Structures of compounds 207213.
Figure 45. Structures of compounds 207213.
Marinedrugs 22 00126 g045
Figure 46. Structures of compounds 214216.
Figure 46. Structures of compounds 214216.
Marinedrugs 22 00126 g046
Figure 47. Representative commercialized β-carboline drugs.
Figure 47. Representative commercialized β-carboline drugs.
Marinedrugs 22 00126 g047
Figure 48. Structure of Norharmane 217.
Figure 48. Structure of Norharmane 217.
Marinedrugs 22 00126 g048
Figure 49. C1-substituted βC compounds 217237.
Figure 49. C1-substituted βC compounds 217237.
Marinedrugs 22 00126 g049
Figure 50. C1-substituted βC compounds 238245.
Figure 50. C1-substituted βC compounds 238245.
Marinedrugs 22 00126 g050
Figure 51. C1-substituted βC compounds 246248.
Figure 51. C1-substituted βC compounds 246248.
Marinedrugs 22 00126 g051
Figure 52. C1-substituted βC compounds 249251.
Figure 52. C1-substituted βC compounds 249251.
Marinedrugs 22 00126 g052
Figure 53. C1-substituted βC compounds 252260.
Figure 53. C1-substituted βC compounds 252260.
Marinedrugs 22 00126 g053
Figure 54. C1-substituted βC compounds 261268.
Figure 54. C1-substituted βC compounds 261268.
Marinedrugs 22 00126 g054
Figure 55. C1-substituted βC compounds 269270.
Figure 55. C1-substituted βC compounds 269270.
Marinedrugs 22 00126 g055
Figure 56. C1-substituted βC compounds 271277.
Figure 56. C1-substituted βC compounds 271277.
Marinedrugs 22 00126 g056
Figure 57. Chemical structure of Shishijimicin A–C (278280).
Figure 57. Chemical structure of Shishijimicin A–C (278280).
Marinedrugs 22 00126 g057
Figure 58. Chemical structures of Manzamines 281291.
Figure 58. Chemical structures of Manzamines 281291.
Marinedrugs 22 00126 g058
Figure 59. Chemical structures of Manzamines 292297.
Figure 59. Chemical structures of Manzamines 292297.
Marinedrugs 22 00126 g059
Figure 60. Chemical structures of Manzamines 298306.
Figure 60. Chemical structures of Manzamines 298306.
Marinedrugs 22 00126 g060
Figure 61. Chemical structures of Manzamines 307312.
Figure 61. Chemical structures of Manzamines 307312.
Marinedrugs 22 00126 g061
Figure 62. N2-substituted βC compounds 313317.
Figure 62. N2-substituted βC compounds 313317.
Marinedrugs 22 00126 g062
Figure 63. C3-substituted βC compounds 318325.
Figure 63. C3-substituted βC compounds 318325.
Marinedrugs 22 00126 g063
Figure 64. Chemical structures of Hyrtioerectine B (326).
Figure 64. Chemical structures of Hyrtioerectine B (326).
Marinedrugs 22 00126 g064
Figure 65. Annelated C1-N2 βC compounds 327339.
Figure 65. Annelated C1-N2 βC compounds 327339.
Marinedrugs 22 00126 g065
Figure 66. Annelated βC compounds 340341.
Figure 66. Annelated βC compounds 340341.
Marinedrugs 22 00126 g066
Figure 67. Naturally occurring marine βC 1,1-dimers 342344.
Figure 67. Naturally occurring marine βC 1,1-dimers 342344.
Marinedrugs 22 00126 g067
Figure 68. Structure of marine βC 9,9-dimer 345.
Figure 68. Structure of marine βC 9,9-dimer 345.
Marinedrugs 22 00126 g068
Figure 69. Structure of manzamine hybrid dimers 346348.
Figure 69. Structure of manzamine hybrid dimers 346348.
Marinedrugs 22 00126 g069
Figure 70. Structure of Kauluamine (349).
Figure 70. Structure of Kauluamine (349).
Marinedrugs 22 00126 g070
Figure 71. Most employed synthetic routes for synthesizing βCs.
Figure 71. Most employed synthetic routes for synthesizing βCs.
Marinedrugs 22 00126 g071
Figure 72. Other classical general synthetic routes towards the synthesis of βCs.
Figure 72. Other classical general synthetic routes towards the synthesis of βCs.
Marinedrugs 22 00126 g072
Figure 73. Representative modern approaches towards the synthesis of βCs.
Figure 73. Representative modern approaches towards the synthesis of βCs.
Marinedrugs 22 00126 g073
Table 1. Bioactivity of Meridianins A–G (4147).
Table 1. Bioactivity of Meridianins A–G (4147).
MeridianinAnticancer
Effects
Prevention of
Alzheimer’s
Disease
Antimalarial
Effects
Antitubercular Effects
A (41)HelaGSK-3β, CK1δ, Dyrk1A and CLK1 2P. falciparumnd 1
B (42)PTP, Hep2, U937, LMM3ndnd
C (43)PTP, Hep2, HT29, RD, U937, LMM3, Hela, MDA-MB-231, A549P. falciparumM. tuberculosis
D (44)PTP, Hep2, HT29, RD, U937, LMM3, Hela, A549ndM. smegatis 3
E (45)PTP, Hep2, U937, LMM3ndndnd
F (46)Hep2, U937, LMM3ndndnd
G (47)HelaDyrk1AP. falciparumM. tuberculosis
1 nd: not determined, 2 Inhived kinases, 3 Antibiofilm activity.
Table 2. Annelated indole alkaloids (350354) and their cytotoxic activity.
Table 2. Annelated indole alkaloids (350354) and their cytotoxic activity.
Marinedrugs 22 00126 i001
Name Annelated IndolStructureCytotoxicity [Reference][Reference]
Antipathine A350SGC-791, Hep-G2[256]
Bromine Indolyl-carbazoles351HL-60, HeLa[257]
Staurosporines352MV4-11[258]
Deoxyapoaranotin353HCT-116 1[259]
Phomazine B354HL-60, HCT-116, K562, MGC-803, A549 1[260]
1 Via apoptosis-inducing effects.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Fernández, S.; Arnáiz, V.; Rufo, D.; Arroyo, Y. Current Status of Indole-Derived Marine Natural Products: Synthetic Approaches and Therapeutic Applications. Mar. Drugs 2024, 22, 126. https://doi.org/10.3390/md22030126

AMA Style

Fernández S, Arnáiz V, Rufo D, Arroyo Y. Current Status of Indole-Derived Marine Natural Products: Synthetic Approaches and Therapeutic Applications. Marine Drugs. 2024; 22(3):126. https://doi.org/10.3390/md22030126

Chicago/Turabian Style

Fernández, Sergio, Virginia Arnáiz, Daniel Rufo, and Yolanda Arroyo. 2024. "Current Status of Indole-Derived Marine Natural Products: Synthetic Approaches and Therapeutic Applications" Marine Drugs 22, no. 3: 126. https://doi.org/10.3390/md22030126

APA Style

Fernández, S., Arnáiz, V., Rufo, D., & Arroyo, Y. (2024). Current Status of Indole-Derived Marine Natural Products: Synthetic Approaches and Therapeutic Applications. Marine Drugs, 22(3), 126. https://doi.org/10.3390/md22030126

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop